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CHAPTER 1 INTRODUCTION
1.1 p120 Catenin

p120 Catenin (p120ctn) is the prototypic member of a subfamily of armadillo-repeat
domain (Arm domain) proteins involved in intercellular adhesion. p120ctn was originally
identified as a substrate of Src oncoprotein [1]. cDNA cloning revealed that it contains an Arm
domain which shares 22% identity with that of β-catenin [2, 3]. Further experiments demonstrated
its direct interaction with multiple types of the cadherins, including E-cadherin, V-cadherin, Pcadherin and VE-cadherin [4-7]. Cadherin function is modulated by a group of catenins, including
α-catenin, β-catenin, -catenin (plakoglobin) and p120ctn, which interact with the cadherin
intracellular domain in direct or indirect manner [8]. β-Catenin binds to the catenin-binding
domain (CBD) of cadherins and functionally links cadherins with the actin cytoskeleton through
α-catenin [9-11], while p120ctn is responsible for stabilizing cadherin-catenin complexes at the
cell surface by interacting with the juxtamembrane domain (JMD) of cadherins (Figure 1.1) [1214]. Through the interaction with cadherin JMD, p120ctn is implicated in various processes,
including supporting lateral clustering of cadherin molecules and adhesive strength [15], as well
as suppression of cell motility [16]. Besides its function in maintenance of the epithelial barrier,
p120ctn also plays important roles in regulation of intracellular signal transduction and gene
transcription [17].
1.1.1 Isoforms of p120 catenin
Most cell types are observed expressing multiple p120ctn isoforms which are derived from
alternative splicing of a single gene [4, 18]. The human p120ctn gene (CTNND1), located on
chromosome 11q12.1, is consist of 21 exons which potentially encode up to 32 protein isoforms
due to alternative splicing. At N-terminus, the use of four different ATGs as the translational start
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site results in the expression of p120ctn isoform 1, 2, 3 or 4 [18]. Furthermore, alternative splicing
of the C-terminal end leads to use of exon A (exon 18) and/or exon B (exon 20), or neither of them.
On rare occasions, p120ctn contains a sequence encoded by exon C (exon 11), which is inserted
within Arm domain. Therefore, the longest isoform of human p120ctn is 1ABC which comprises
968 amino acid residues (Figure 1.2) [19]. Various combinations of these N- and C-terminal exons
could generate multiple p120ctn isoforms observed as diverse bands on SDS-PAGE. The tissue
type-specific expression of p120ctn isoforms was obvious, and the presence of isoforms varies in
abundance among different cell types [18]. These cell type-associated expression patterns of
p120ctn isoforms implies that various isoforms of p120ctn might have distinct or preferential
functions [20, 21]. The functional consequence of the multitude of p120ctn variants has not been
very clear. The alternative splicing usually affects only the N- and C-terminal domains, so the Arm
domain is intact and free to bind to cadherins. The mesenchymal and motile cells, such as
macrophages and fibroblasts, preferentially express p120ctn isoform 1A, whereas the sessile cells,
such as epithelial cells, predominantly express short isoforms, such as p120ctn 3A. Non-adherent
cells, including B cells and T cells do not express detectable level of p120ctn. p120ctn isoform 1
and 3 are observed most frequently among different cells. p120ctn isoform 4 contains the Arm
domain without the N-terminal regulatory (phosphorylation) domain. In contrast to other isoforms,
p120ctn isoform 4 mRNA has been detected, but is rarely expressed as a protein [18, 22].
The expression level and pattern of p120ctn isoforms can be changed in the cells in
response to variant factors. Heterogeneous expression patterns of p120ctn isoforms in human
tumor cells revealed the association between functions and p120ctn isoforms [22]. Some poorly
differentiated tumor cells failed to express particular p120ctn isoforms which were typically
observed in well-differentiated cell lines. Hence, the distinct expression pattern of p120ctn
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isoforms in human tumors might contribute to malignancy, which may partially result from its
functions in stabilization and regulation of membrane cadherins [22]. For example, different
p120ctn isoforms showed a dramatic effect on the morphology of human pancreatic tumor cells
(S2-013 cells) in culture. S2-013 cells originally expressed very low level of p120ctn and showed
a moderate mesenchymal morphology. Re-expression of p120ctn 1A enhanced the mesenchymal
phenotype with cells exhibiting elongated shapes and increased cell motility within the monolayer.
Re-expression of p120ctn 3A and 4A induced epithelial changes in cell morphology [23]. Based
on those observations, cell type-dependent expression of p120ctn isoforms is correlated to the cell
morphology and functions. Different isoforms may regulate cadherin complex functions by
recruiting distinct binding partners or signaling molecules to the cadherin complex in response to
variant stimuli. The regulated expression of multiple p120ctn isoforms might provide a mechanism
for fine-tuning the activities of cadherins in different cell types.
1.1.2 Structure of p120 catenin
p120ctn consists of four distinct functional regions, including a N-terminal coiled-coil
domain, a regulatory or phosphorylation domain, an Arm domain containing ten armadillo repeats
and a short C-terminal tail (Figure 1.2). The coiled-coil domain is only present in the long isoform
(isoform 1). N-terminal regulatory domain is present in all except the shortest isoform (isoform 4).
All p120ctn isoforms contain a central Arm domain, a repeating ∼46 amino acid motif composed
of three α-helices, which was first characterized in the Drosophila segment polarity protein
Armadillo Tandem [2]. Armadillo repeat units fold together as a superhelix, which provides a
versatile platform for interactions with other protein partners [24]. p120ctn interacts via its central
Arm domain with its partners including cadherins, RhoA, transcription factor Kaiso and
microtubules [25]. The N-terminal regulatory domain is important for signal integration. It
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contains multiple tyrosines, serines and threonines which can be modified by tyrosine kinases and
serine/threonine kinases, as well as phosphatases. In addition to being a substrate for the kinases
and phosphatases, p120ctn can also bind to and regulate the function of non-receptor tyrosine
kinases such as Fer, Fyn and Yes, and the tyrosine phosphatases PTPμ and SHP-1 [25].
1.1.3 Functions of p120 catenin
Stabilization of adherens junction by association with cadherins
Cadherins comprise a superfamily of transmembrane cell–cell adhesion molecules
involved in tissue development, morphogenesis, wound healing, and tumor malignancy [26, 27].
The extracellular domains of cadherins interact in a homophilic and Ca2+-dependent fashion to
form adherens junctions between adjacent cells. The cytoplasmic domains interact with the
catenins. C-terminal catenin binding domain interacts with α-, β- and γ-catenin, which bridge and
regulate the interaction of the cadherin complex with the actin cytoskeleton [10, 28]. Cadherins
bind through the juxtamembrane domain to the Arm domain of p120ctn (Figure1.1) [15, 29]. In
cadherin-deficient cell model systems, p120ctn-uncoupled E-cadherin mutants failed to induce the
strong cell adhesion observed in cells transfected with wild-type E-cadherin [29, 30]. Moreover,
the dissociation of p120ctn from the cadherin complex resulted in endocytic internalization of
cadherins [12, 31, 32]. Endocytosis of cadherins has been observed in cells during development,
epithelial to mesenchymal transitions, and in response to growth factors and tumorigenic signaling
agonists [33-35]. E-cadherin trafficking plays a pivotal role in E-cadherin-mediated cell–cell
adhesions. Endocytosed cadherins can be either degraded in the lysosomes, or recycled to the
plasma membrane via a process that involves p120ctn and Rap1 GTPase [36, 37]. p120ctn binding
to the cadherin regulates cadherin membrane levels by preventing cadherin endocytosis. The
structure of p120ctn in association to E-cadherin revealed that both “dynamic” and “static”
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interactions contribute to the binding of p120ctn Arm domain with the cadherin JMD. The residues
of E-cadherin involved in this interaction are also implicated in clathrin-mediated endocytosis and
Hakai-dependent ubiquitination of E-cadherin [14]. Thus, p120ctn binding to cadherin physically
impedes the interaction of cadherin with either clathrin or E3 ligases, which results in suppression
on cadherin endocytosis and degradation [38, 39]. p120ctn may also serve as a scaffold for
molecules which directly regulate the functions of cadherin/catenin complex proteins. For
example, p120ctn can recruit a number of kinases and phosphatases that could affect the formation
and stability of adherens junctions by changing the phosphorylation status of the entire
cadherin/catenin complex, including p120ctn itself [34, 40]. Thus the membrane-associated
p120ctn is a master regulator which is responsible for stabilizing cadherin expression at the plasma
membrane and maintaining the structure of adherens junctions [41].
Regulation of Rho GTPase signaling
Rho GTPases (such as RhoA, Rac and Cdc42) are a subgroup of the Ras superfamily of
small GTP-binding proteins that are involved in regulating a wide spectrum of cellular functions.
They act as intracellular switches that control multiple signaling cascades by switching between
active GTP-binding and inactive GDP-binding states. Exchanges in the GTP- and GDP-state cycle
are generally regulated by guanine nucleotide dissociation inhibitors (GDIs), GTPase-activating
proteins (GAPs) and guanine nucleotide exchange factors (GEFs). GDIs associate with GDPbound Rho GTPases to prevent their membrane-association and thus sequester them in an inactive
state. GEFs activate Rho GTPases by catalyzing nucleotide exchange from GDP to GTP. GAPs
inactivate Rho GTPase by promoting GTP hydrolysis. In their active state, Rho-GTPases interact
with over 60 different target effectors [42]. Rho GTPases and their effectors are mediators of
cytoskeletal dynamics [43] and cadherin-mediated adhesion [44-47] by transducing extracellular
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signals to the actin cytoskeleton. They play important roles in regulating cell migration, motility
and morphology [48, 49]. They also regulate gene transcription by activating MAPK and NF-κB
signaling pathways [50-55].
RhoA, Rac and Cdc42 are the most well studied members of Rho GTPases. Initial
experiments demonstrated that p120ctn can inhibit RhoA and activate Rac and Cdc42, resulting in
disruption of stress fibers and focal adhesions, as well as promoting migration of cells [56-58].
The interaction of p120ctn with Rho GTPase extends the effects of p120ctn to additional events,
including cell survival, growth, and invasiveness because of Rho GTPase-mediated signaling
cascades. Strong evidence revealed that cytosol p120ctn acts mainly through its direct interaction
with RhoA. The mechanism by which p120ctn inhibits RhoA was revealed by in vitro GTP
exchange assays. It suggested that p120ctn could inhibit the intrinsic GDP/GTP exchange activity
of RhoA in a manner comparable to that of GDI [57]. The direct interaction between p120ctn and
RhoA sequesters RhoA in an inactive GDP-bound state. Two domains of p120ctn have been
identified being essential for the inhibitory interaction with RhoA: a central region (including
amino acids 622-628) [57, 59] and an N-terminal region (including amino acids 131-156) [60, 61].
The interaction of p120ctn with RhoA is regulated by phosphorylation of p120ctn. For example,
the interaction is promoted via tyrosine phosphorylation of p120ctn at Tyr217 and Tyr228 by Src,
or destabilized by phosphorylation at Tyr112 by Fyn [61].
p120ctn could activate Cdc42 and Rac1, which might result from its interaction with the
guanine nucleotide exchange factor Vav2 [58]. The activation of Rac1 by p120ctn might be
another mechanism involved in its inhibitory effect on RhoA, since activated Rac1could inhibit
RhoA activities indirectly in some cells via reactive oxygen species (ROS), p190 RhoGAP and
cadherin homophilic ligation [62-64].
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Regulation of gene transcription via interaction with Kaiso
p120ctn is also a regulator of gene transcription via its interaction with transcription
suppressor Kaiso. Kaiso binds to both a specific consensus Kaiso binding site (TCCTGCNA) and
methylated CpG dinucleotides within target gene promoters [65]. Kaiso mediates DNA
methylation-dependent transcriptional repression through its interaction with the nuclear receptor
corepressor (NCoR) [66, 67]. p120ctn is capable of nucleocytoplasmic trafficking since it has
both nuclear localization signal and nuclear export signal [68, 69]. Its interaction with zinc finger
domain of Kaiso interrupts Kaiso-DNA binding, followed by translocation and sequestration of
Kaiso into cytosol. The promoters of some Wnt/β-catenin target genes contain the sequencespecific binding sites for Kaiso. Kaiso acts as a transcriptional repressor to antagonize β-cateninmediated transcriptional activation [70, 71]. Hence the interaction of p120ctn with Kaiso could
facilitate Wnt/β-catenin signaling. Interestingly, Wnt signaling also affects transcriptional activity
of Kaiso by regulating the phosphorylation and degradation of p120ctn [72]. Like β-catenin,
p120ctn could transport into nucleus to regulate gene expression. However, the signals that trigger
p120ctn nucleocytoplasmic trafficking has not been very clear. The transmembrane adhesion
protein Mucin-1 might be one of the triggers for p120ctn nuclear localization [73].
1.1.4 Phosphorylation of p120 catenin
p120ctn is an efficient substrate for tyrosine kinases and serine/threonine kinases [1, 74,
75]. N-terminal regulatory domain contains multiple sites identified for phosphorylation by
tyrosine kinases and serine/threonine kinases. p120ctn is highly tyrosine phosphorylated in Srctransformed cells [1, 4], and in response to a group of growth factors including platelet-derived
growth factor, colony-stimulating factor 1, epidermal growth factor [76, 77], hepatocyte growth
factor [78, 79], and vascular endothelial growth factor (VEGF) [80]. Hence, p120ctn is a substrate
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of both non-receptor- and ligand-activated transmembrane receptor tyrosine kinases. p120ctn is
not tyrosine phosphorylated in cells expressing non-myristylated alleles of Src [1, 77] or in
cadherin-deficient cells when p120ctn is residing in the cytoplasm. These studies indicated that
p120ctn phosphorylation requires the recruitment of the kinases to the membrane and the intact
structure of cadherin-catenin complex [30].
The stability and dynamics of the adherins junction are regulated by protein tyrosine
kinases and phosphatases which are able to modulate the phosphorylation state of adherins junction
components such as -catenin and p120ctn. In some cell contexts the phosphorylation is associated
with loss of epithelial differentiation and increased invasiveness in human cancer cells [78].
p120ctn regulates the stability of adherens junction not only through its direct interaction with
cadherins, but also via its interactions with multiple non-receptor tyrosine kinases and
phosphatases. Some non-receptor protein tyrosine kinases such as Fer and Fyn are constitutively
associated with p120ctn which in turn is their substrate [81, 82]. Interfering with the Fer-p120ctn
interaction would result in the disruption of adherins junction complex in areas of cell-cell contacts
[83]. Tyrosine phosphorylation of p120ctn increases the binding affinity of Fer or Fyn to adherens
junction complex [81]. Therefore, p120ctn is not only the major substrate for kinases but also plays
as a scaffolding and regulatory protein in adherens junctions by recruiting tyrosine kinases and
phosphatases which can further modulate α-catenin/β-catenin and β-catenin/cadherin interactions
[81, 84].
p120ctn is also found phosphorylated on Ser/Thr residues in different cell lines [85-87].
Multiple residues of serine and threonine of p120ctn have been identified as phosphorylation sites
[88]. For example, Protein kinase C (PKC) can promote phosphorylation of Ser879, and
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dephosphorylation of several sits, such as Ser268, Ser288, Thr310 and Thr916, which is associated
with stabilization of cell–cell adhesion [88-91].
Significant dephosphorylation of p120ctn has been observed in endothelial cells in
response to inflammatory agents, such as histamine, thrombin and lysophosphatidic acid [92,
93], via PKC-dependent and PKC-independent pathways in modulating its serine/threonine
phosphorylation. VEGF stimulates both tyrosine phosphorylation and serine/threonine
dephosphorylation of p120ctn in endothelial cells. Histamine and activators of PKC have a similar
effect to that of VEGF on phosphorylation of p120ctn. Since VEGF and histamine could increases
vascular permeability, these studies suggested that the phosphorylation state of p120ctn may
contribute to regulating vascular permeability via controlling cell–cell adhesion [94].
The functions of combinatorial phosphorylation of p120ctn have not been very clear. A
systematic identification and subsequent mutational analysis of tyrosine and serine/threonine
residues targeted by kinases and phosphatases might be possible to address the physiological role
of phosphorylation of p120ctn.
1.2 LPS/TLR4 mediated inflammation in macrophage
1.2.1 Toll-like receptor
Toll-like receptors (TLRs) are human homologue of the Drosophila toll protein which has
been shown to induce the innate immune response in adult Drosophila [95]. TLRs are prototype
of pattern-recognition receptors (PRRs) that can detect both pathogen-associated molecular
patterns (PAMPs) from microorganisms, and danger-associated molecular patterns (DAMPs) from
damaged tissues [96, 97]. They belong to the type-1 transmembrane receptor family and are
evolutionarily conserved proteins among vertebrates and invertebrates [95, 98]. TLRs are
characterized by multiple copies of leucine-rich repeats in the extracellular domain and a
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cytoplasmic Toll/ interleukin-1 receptor homology (TIR) domain. Mammalian TLRs comprise a
large family including 13 members. TLR1–9 are conserved between human and mouse. TLR10
is presumably functional in the human. TLR11-13 are functional in mouse [99]. TLRs primarily
recognize invading pathogens and initiate an immediate innate immune response, followed by a
long-lasting adaptive immune response. Activation of TLRs provokes a variety of immune
responses, including the expression of proinflammatory cytokines such as interleukin (IL)-1 and
IL-12, chemokines such as IL-8, and inflammatory effector substances such as nitric oxide (NO)
[98].
TLR4 was first identified as the receptor recognizing lipopolysaccharide (LPS), a major
component of the outer membrane of Gram-negative bacteria [100]. In addition to the recognition
of LPS, TLR4 from various species could recognize several other components of pathogens such
as mannuronic acid polymers from Gram-negative bacteria [101], teichuronic acid from Grampositive bacteria [102], and viral components such as the F protein of respiratory syncytial virus
[102, 103]. It also binds to endogenous molecules, such as heat shock proteins [104, 105], type III
extra domain A of fibronectin [106, 107] and saturated fatty acids [108, 109]. Hence, both
exogenous pathogens and endogenous molecules produced during abnormal situations, such as
tissue damage, are able to trigger TLR4-dependent pathways [110].
TLR4 can be detected in multiple types of tissue, such as lung, colon and spleen [111].
Analyses of total RNA showed that the predominant TLR4 expressing cells are monocytes in
human peripheral blood mononuclear cells (PBMCs) [112, 113]. Exposure of monocytes or
macrophages to LPS or to proinflammatory cytokines increases the expression of TLR4 [111] . In
addition, TLR4 expression may also be up-regulated by high concentration of glucose in human
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monocytes, which revealed one of the possible mechanism associated with high glucose-induced
NF-B activity and proinflammatory cytokine secretion [114].
1.2.2 TLR4-mediated signaling pathways
TLR4 forms a complex on the cell surface with other proteins including CD14 and myeloid
differentiation factor 2 required for ligand recognition and signal transduction in high efficiency
[115-117]. LPS is initially bound in the serum by LPS binding protein which transfers LPS to
CD14 [118]. Upon LPS binding at the cell surface, TLR4 receptors dimerize through interactions
between their intracellular TIR domains, resulting in conformational changes. The subsequent
signaling process involves the recruitment of TIR-domain-containing adapter molecules to the
cytoplasmic tail of TLR4 cluster via homophilic interactions between the TIR domains, which
provide a platform enabling the recruitment and activation of the downstream kinases. The further
propagation of signals ultimately leads to the activation of specific transcription factors, such as
activator protein 1 (AP-1) and NF-B, as well as inflammatory gene expression (Figure 1.3) [98].
Four TIR-domain-containing adapter molecules are recruited to mediate TLR4 signaling
pathways: myeloid differentiation factor 88 (MyD88); TIR-domain-containing adapter protein
(TIRAP); TIR-domain-containing adapter inducing interferon-β (TRIF), and TRIF-related adapter
molecule (TRAM). Through these four adaptors, TLR4 initiates intracellular signaling by at least
two major pathways (Figure 1.3): (1) MyD88-dependent/TIRAP–MyD88 pathway. Upon
stimulation, MyD88 recruits a cytoplasmic adapter protein IL-1 receptor-associated kinase
(IRAK). Activated IRAK then associates with tumor necrosis factor receptor-associated factor 6
(TRAF6), resulting in the activation of two signaling pathways. One pathway leads to activation
of AP-1 transcription factors through activation of MAPK cascade. Another pathway activates IκB
kinase (IKK) complex. Activated IKK complex induces phosphorylation and subsequent
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degradation of IκB, which leads to nuclear translocation of transcription factor NF-κB. MyD88depedent pathway regulates the activation of MAPK and NF-κB signaling, and the production of
related inflammatory cytokines such as IL-1 and IL-12. (2) MyD88-independent TRIF–TRAM
pathway, which activates the transcription factor interferon regulatory factor-3 (IRF3) that leads
to the subsequent expression of the genes encoding type I interferons (IFNs) and co-stimulatory
molecules. This TRIF–TRAM pathway also increases tumor necrosis factor (TNF)-α production
and secretion. The subsequent binding of secreted TNF-α to its receptors leads to NF-κB
activation. Thus, the TRIF–TRAM pathway is also responsible for the late phase NF-κB activation
through TNF-α signaling [99, 116, 119, 120].
1.3 Autophagy
Autophagy refers to the conserved catabolic process in which cytoplasmic components are
delivered to lysosome for degradation [121, 122]. Three types of autophagy have been identified,
including

macroautophagy,

microautophagy

and

chaperone-mediated

autophagy.

In

macroautophagy, the cytoplasmic components are sequestered in the double-membrane vesicles
(autophagosome), followed by fusion with the lysosome to form autolysosome where the cargo is
degraded [123]. Microautophagy refers to cytosolic components being directly taken up by the
lysosome through invagination of the lysosomal membrane [124]. Both macroautophagy and
microautophagy are capable of engulfing large molecules and organelles through selective and
non-selective mechanism. In chaperone-mediated autophagy, targeted proteins are translocated
across the lysosomal membrane with chaperone proteins (such as heat shock cognate protein Hsc70) through the lysosomal membrane receptor lysosomal-associated membrane protein 2A
(LAMP-2A), resulting in unfolding and degradation of the target protein [125].
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Autophagy occurs at low basal levels in cells to maintain homeostasis [126]. It is
upregulated when cells suffer nutrient starvation and growth factor withdrawal, or undergo
structural remodeling during developmental transitions, or remove the damaging cytoplasmic
components during oxidative stress, infection and protein aggregate accumulation [121, 127].
Macroautophagy (henceforth referred to as ‘autophagy’) has been profoundly studied in various
research areas since it plays important roles in both health and multiple diseases [128-130].
1.3.1 Process of autophagy
Autophagy is initiated by formation of a curved membrane structure, phagophore, in the
cytoplasm. The phagophore elongates to form a double-membrane structure named
autophagosome by recruiting and accumulating additional proteins. A portion of the cytoplasm
along with the cellular components is enclosed in the autophagosome which is further fused with
lysosome to form an autolysosome. The enclosed cargo is then degraded via proteolysis. In order
to study the molecular mechanism, the process of autophagy is divided into five stages described
as initiation, elongation, maturation, fusion and degradation (Figure 1.4) [131]. The process of
autophagy is mediated and regulated by several molecular complexes which are composed of
proteins encoded by AuTophaGy-related (ATG) genes [132]. More than 30 products of these genes
have been originally characterized in yeast, and many orthologs have subsequently been identified
as autophagy-related proteins in higher eukaryotes [133, 134].
Initiation and elongation
During the initiation stage, the autophagic membrane forms a phagophore, and then
elongates. Several different cellular organelles have been considered as the autophagic membrane
source, including the endoplasmic reticulum (ER), Golgi, mitochondria and plasma membranes
[135-138]. It's suggested that SNARE (soluble N-ethylmaleimide-sensitive factor attached protein
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receptor) proteins mediate homotypic fusion of phagophore precursors, which contributes to
recruitment of proteins that enable subsequent maturation of autophagosome [139]. The initiation
and elongation stages are mediated by two major steps of protein processing and conjugation
(Figure 1.5). The mechanisms of both conjugation systems resemble protein ubiquitination with
corresponding enzymes to the E1 and E2 in ubiquitin ligation. Atg12 is conjugated to Atg5 by
Atg7 (an E1-like protein) and Atg10 (an E2-like protein). Atg5 interacts further with Atg16L1 to
form Atg12–Atg5-Atg16L1 complex (also called the Atg16L1 complex), a multimeric complex
through the homo-oligomerization of Atg16L1. The Atg12–Atg5–Atg16L1 complex is recruited
to the membrane to function as an E3-like ligase to mediate the lipidation of microtubuleassociated protein 1 light chain 3 (MAP1LC3/LC3, an ortholog of yeast Atg8) in the process
assisted by Atg7 (an E1-like protein) and Atg3 (an E2-like protein). A pro-LC3 is first cleaved at
C-terminus

by

Atg4

to

generate

LC3-I,

followed

by

conjugation

to

the

lipid

phosphatidylethanolamine (PE) to form LC3-II (the lipid-conjugated form). LC3-II is anchored
into the membrane of autophagosome to mediate the expansion and fusion of the isolated
autophagic membrane [140, 141]. Furthermore, LC3 molecules form a platform on the autophagic
membrane to influence autophagosome formation by mediating assembly and disassembly of
protein complexes at the membrane. [142, 143].
Maturation, fusion and degradation
The autophagosome may fuse with a late endosome to form an amphisome [144], or fuse
directly with the lysosome to generate an autolysosome in mammals [145]. In yeast, the
autophagosome fuses with the vacuole and then releases the inner vesicle termed an autophagic
body [146]. The inner vesicle of the autophagosome, together with the sequestered cargoes, is
degraded, followed by the release of the breakdown products into the cytosol for reuse [147, 148].
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Before the closure of the membrane of an autophagosome, the Atg proteins bound to the membrane
dissociate from autophagosome. LC3-II is present on both sides of the phagophore and the early
autophagosome. It is released from the outer membrane by Atg4-dependent deconjugation during
autophagosome maturation [142]. Since LC3-II is found on the inner and outer surfaces of the
autophagosome and remains bound to the membrane even after lysosomal fusion, LC3-II is widely
used as a marker for identifying autophagosomes in cells [133].
1.3.2 Signaling pathways for regulation of autophagy
Several protein complexes containing Atg proteins are involved in the signaling
responsible for initiation and elongation stages of autophagy. Different reasons for autophagy are
mediated through various signaling pathways. One of the regulators is mammalian target of
rapamycin (mTOR). mTOR is the major negative regulator that shuts off autophagy when the
growth factors and nutrients are abundant [130]. The activity of mTOR depends on a variety of
upstream signals that include the energy and nutrient status of the cells. In nutrient-rich conditions,
mTOR interacts with the ULK1 kinase complex (ULK1-Atg13-FIP200 complex) and
phosphorylates ULK1 and Atg13 to suppress autophagosome formation. Upon starvation, the
ULK1 kinase complex is activated due to the inhibition of mTOR activity. Activated ULK1
complex leads to the activation of Beclin-1/Vps34 complex which consists of Vps34 (the class III
PI3 kinase) and Beclin-1 (a mammalian ortholog of yeast Atg6). The Beclin-1/Vps34 complex can
also be activated by other proteins that interact with Beclin-1, including UV radiation resistance
protein and Ambra-1 (activating molecule in Beclin-1-regulated autophagy protein 1) [149]. Once
being activated, Beclin-1/Vps34 complex can further activate the Atg proteins, and phosphorylate
phosphatidylinositol to generate phosphatidylinositol 3-phosphate which is an essential lipid
component of the autophagosome [150-153]. The activity of Beclin-1 is inhibited by its interaction
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with B-cell lymphoma/leukemia (Bcl)-2 or Bcl-XL. This interaction can be disrupted by
phosphorylation of Bcl-2 and/or Beclin-1, or ubiquitination of Beclin-1. For example, under the
condition of nutrient starvation, the stress-activated JNK1 phosphorylates Bcl-2, which induces
the dissociation of Bcl-2 from Beclin-1. Upon stimulation of TLR4, TRAF6 and the
deubiquitinating enzyme A20 can also control the initiation of autophagy through regulating lysine
(K) 63-linked ubiquitination of Beclin-1 [154]. Thus dissociated Beclin-1 can interact with other
members of the autophagic machinery and induce autophagy [155]. Autophagy can be induced by
some drugs such as rapamycin which inhibits mTOR activity [156].
LC3 is another regulating point of autophagy. Phosphorylation of LC3 by protein kinase A
inhibits autophagy by suppressing recruitment of LC3 molecules to autophagosome [157]. It was
also observed that both rapamycin and pathological inducers of autophagy can cause
dephosphorylation of endogenous LC3, which further proved that phosphorylation of LC3 might
be an important regulatory mechanism during autophagy [157].
1.3.3 Selective autophagy
The balance between the biosynthesis and the degradation of cellular components is of
importance for normal cellular homeostasis and health [158]. Autophagy has been thought as an
essential non-selective pathway for bulk degradation induced by nutrient deprivation [159, 160] .
However, accumulating evidence has shown selective autophagy contributes to intracellular
homeostasis in non-starved cells by selective degradation of components including aberrant
protein aggregates, lipid droplets, dysfunctional and superfluous organelles and intracellular
pathogens [161-164]. In selective autophagy, the cargo has to be specifically recognized and
effectively tethered to a nascent autophagosome. Selectivity in autophagy is achieved by cargo
receptor proteins, which are able to tether the selected cargo to a nascent autophagosome by
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simultaneous interaction with both the cargo and LC3-family proteins on the isolation
membrane of autophagosome [161]. The post-translational modifications such as protein
ubiquitination, have an important role in ensuring substrate recognition and selectivity [165]. The
recognition of ubiquitinated substrates is achieved by molecular adaptors including p62, NBR1,
NDP52, VCP and optineurin, which target ubiquitinated cargo to autophagy-associated proteins,
such as the LC3 family members [166, 167].
A variety of cargo receptors are responsible for recognition of different cargoes. For
example, in mammalian cells, nuclear receptor coactivator 4 (NCOA4) is the cargo receptor for
ferritin during ferritinophagy [168]. Ferritin forms complex to sequester excessive intracellular
iron [169]. Under conditions of low intracellular iron, NCOA4 receptor binds to ferritin heavy
chains and deliver the ferritin complexes into the lysosomal compartment via selective autophagy
[168, 170]. Degradation of ferritin in the lysosomes ultimately leads to the release of iron back
into the cytosol [171].
Another well-studied cargo receptor p62, also known as sequestosome 1 (SQSTM1)
mediates the degradation of ubiquitinated molecules such as aggregated proteins or cytosolic
bacteria [172, 173]. The cargo receptor p62 binds to ubiquitin through its ubiquitin-associated
(UBA) domain with a relatively low affinity. The affinity of p62 for polyubiquitin chain is
increased by phosphorylation of serine 403 within its UBA domain [174]. The N-terminal
Phox/Bem 1 (PB1) domain of p62 mediates its homo-oligomerization. Oligomerization of p62
stabilizes binding to the cargo material on which ubiquitin is concentrated [175]. Different
ubiquitin chains trigger different cellular degradation processes. The preferential interaction of p62
with certain types of ubiquitin chain might contribute to selectivity regulation during selective
autophagy. K48-linked ubiquitin chains are recognized by the proteasome and therefore mediate
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proteasomal degradation of the substrates. K63-linked ubiquitin chains are associated with
selective autophagy [176, 177]. It has been shown that oligomeric p62 preferentially binds to K63linked ubiquitin chains, as well as mono-ubiquitin [178].
The selected cargoes target to a nascent autophagosome via the interaction between LC3family proteins and cargo receptors through their conserved LC3-interacting region (LIR) motif,
also known as Atg8-interacting motif (AIM). The consensus for the core LIR motif is
(W/F/Y)XX(L/I/V), where X is any other residue. This sequence is surrounded by at least one
acidic residue. Structural studies have revealed that the hydrophobic residues of the core LIR motif
dock into two hydrophobic pockets in the ubiquitin-like domain of LC3, whereas adjacent acidic
residues form electrostatic interactions with the N-terminal arm of LC3 molecules. The core LIR
motif adopts an extended β-conformation and forms an intermolecular parallel β-sheet with the β2
strand of LC3 [179].
1.3.4 General functions of autophagy
Autophagy has been found associated with a broad spectrum of biological processes
including aging, development, degenerative diseases, and cancer [130, 180]. Autophagy is
important in mammals for development and differentiation such as preimplantation [181], survival
during neonatal starvation [159], as well as cell differentiation during erythropoiesis [182],
lymphocyte differentiation [183, 184], and adipogenesis [185].
Autophagy is also associated with the pathogenesis of various diseases. Tissue-specific
knockout studies in mice indicate autophagy plays a critical role in intracellular protein and
organelle quality control, which is associated with the pathogenesis of several genetic diseases
including liver disease, neurodegenerative diseases, and myodegenerative diseases. They may be
caused due to either the failure of autophagosomes to fuse with lysosomes or the aggregation of
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misfolded proteins that exceed the autophagic clearance capacity [186-188]. Autophagy is also
found associated with tumorigenesis. The expression of Beclin-1 has been found decreased in
human breast, ovarian, and brain tumors [189, 190]. Gene transfer of Beclin-1 can inhibit the
growth of tumor cell lines and the tumorigenicity of human breast carcinoma cells in mouse
xenograft models [191, 192]. Thus, Beclin-1 might be a candidate of tumor suppressor, which is
the first specific link between the autophagy and human cancer. Moreover, several tumor
suppressors involved in the inhibition of mTOR signaling, such as phosphatase and tensin homolog
(PTEN), tuberous sclerosis (TSC) 1, and TSC2, could stimulate autophagy [193]. Conversely,
oncogene products such as class I PI3K and Akt could inhibit autophagy through activating mTOR.
Tumor suppressor p53 regulates autophagy under genotoxic and other stresses [194].
1.3.5 Autophagy in immunity
The functions of autophagy in immunity have been profoundly studied recently [195].
Autophagy not only maintains cellular homeostasis under conditions of endogenous distress, but
also plays a primordial role in controlling intracellular pathogens in different species from
unicellular organisms to human [196]. Autophagy represents one of the most primitive examples
of innate immune responses. In mammals, the functions of autophagy have evolved to incorporate
into multiple pathways of innate and adaptive immunity, including
microorganisms [197, 198], as well as

direct elimination of

regulating inflammation [199], MHC II-restricted

endogenous antigen presentation [200, 201], lymphocyte homeostasis [202], the secretion of
immune mediators [203], and central tolerance [184]. The functions of autophagy in regulating
immunity has been also proved by the evidence that autophagy contributes to chronic
inflammatory diseases [204-206].
Direct elimination of microorganisms
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The antimicrobial

functions

of autophagy provide barriers against invading

microorganisms. It includes xenophagy which is the selective uptake and degradation of
intracellular microorganisms via autophagy [207], and LC3-associated phagocytosis which
involves the engagement of the autophagic machinery as the bacterium is confined in the
phagosome [208, 209]. Some invading microorganisms or the damaged host membranes
associated with the pathogen express some molecular tags, such as ubiquitin, galectin and
membrane phospholipid modifications. Those tags can be recognized by autophagy receptors
which recruit the autophagic machinery and initiate autophagy [166, 210-212]. Autophagyassociated proteins have been shown to directly target microbial proteins, such as Atg5 which can
target surface protein VirG of bacteria Shigella and promote selective autophagy of bacteria [213].
Regulation of innate immunity
Many signals which can initiate immune response also induce autophagy, such as PAMPs
[214-216], DAMPs (including ATP, ROS and misfolded proteins) [217], JNK [218], and IKK
[219]. Pathogen can initiate autophagy at multiple stages [220]. Autophagy can be initiated during
adhesion and uptake of bacteria by the host cells, or during phagocytosis of bacteria by
macrophages [209, 214, 221]. After bacterial uptake, autophagy is induced by pathogen-inflicted
cell damage or the intracellular bacteria [211-213, 222, 223]. The initiation of autophagy after
virus infection occurs at different stages of the virus life cycle [224-228]. The proinflammatory
cytokines, including IL-1, IL-2, IL-6, TNF-α, transforming growth factor-β and IFN-γ, can induce
autophagy; whereas TH2 cell-associated cytokines, such as IL-4, IL-10, and IL-13, can inhibit
autophagy [229, 230]. IL-1β could induce autophagy leading to autophagic elimination
of Mycobacterium tuberculosis in macrophages, which was dependent on TANK-binding kinase
1 (TBK-1) [231]. TBK1 is necessary for autophagic maturation and autophagic machinery
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assembly. It can phosphorylate p62 on Ser403, which is essential for p62 in autophagic
clearance. IL-1β activates NF-B signal pathway through TRAF6 [232] which is also involved
in the activation of autophagy via the subsequent TRAF6-dependent K63-linked ubiquitination of
Beclin-1 [154].
In response to infection, both innate and adaptive immune system are activated to control
infection. At the same time some specific responses that limit detrimental immune activation and
inflammation are also initiated. Research on autophagy reveals autophagy proteins function in
both the activation and inactivation of innate immune signaling, such as type I IFN signaling and
inflammasome activation [220].
The autophagy pathway can activate the production of type I IFN in plasmacytoid dendritic
cells by delivering viral nucleic acids to endosomal TLRs [227]. Single-stranded RNA viruses are
recognized by the RIG-I-like receptors (RLRs) in the cytosol. RLRs signaling results in the
production of antiviral cytokine type I IFNs. Atg5-deficient cells exhibited enhanced RLR
signaling and increased IFN secretion. In the absence of autophagy, accumulated dysfunctional
mitochondria, as well as dysfunctional mitochondria-associated ROS were mainly responsible for
the enhanced RLR signaling [233]. Double-stranded DNA (dsDNA) can also induce potent innate
immune responses via the induction of type I IFN and IFN-inducible genes. Upon sensing dsDNA,
stimulator of IFN genes (STING) moves from ER to the Golgi apparatus and finally to the
cytoplasmic to assemble with TBK1. The translocation and assembly of the signal transducers,
STING and TBK1, are required for dsDNA-triggered innate immune responses. However, STING
also co-localizes with the autophagy protein LC3 and Atg9a after dsDNA stimulation. The loss of
Atg9a greatly enhances the assembly of STING to TBK1 by dsDNA, resulting in aberrant
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activation of the innate immune response. Thus autophagy could limit dsDNA-induced innate
immune responses by regulating the assembly of STING and TBK1 [234].
The inflammasomes are multiprotein complexes activated by infection or stress.
Inflammasomes in immune cells are fundamental in the innate immunity against microbes. They
are composed of nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) proteins
and functions as signaling platforms for the activation of caspase-1 and subsequent maturation of
the proinflammatory cytokines IL-1β and IL-18 [235]. The aberrant activation of inflammation is
involved in the pathogenesis of autoimmune and inflammatory diseases , as well as metabolic
disorders [236]. Several studies have revealed a link between autophagy and inflammasome
activation, and the potential roles in disease progression [237-239]. For example, Atg16L1deficient mice suffer severe colitis induced by dextran sulfate sodium, which can be alleviated by
neutralization of IL-18 and IL-1β. This research indicated that the severe colitis probably resulted
from the enhanced inflammasome activity resulted from defective autophagy [199]. Activation of
inflammasomes in macrophage could lead to autophagosome formation via the activation of small
G protein RalB, a direct trigger of autophagosome formation. Activated autophagy is able to recruit
p62 and then target ubiquitinated inflammasomes for degradation via autophagy [240]. Hence,
autophagy and inflammasome activation are mutual regulated.
In addition to directly regulating inflammatory signaling, the autophagy pathway might
prevent tissue inflammation through its role in apoptotic corpse clearance. The efficient clearance
of apoptotic cells prevents secondary necrosis and excess inflammation triggered by released
danger signals from dead cells. Mice lacking Atg5 display a defect in apoptotic corpse engulfment
during embryonic development. Autophagy contributes to the clearance of dead cells by a
mechanism that involves the generation of ATP-dependent engulfment signals [241]. Involution
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is the process of post-lactational mammary gland regression which involves the death of secretory
epithelial cells and stroma remodeling. It was revealed that Beclin-1- or Atg7-deficient mammary
epithelial cells were defective in engulfment of apoptotic bodies, which resulted in higher levels
of involution-associated inflammation in Atg-deficient tissues. Beclin-1 or Atg7 knockdown could
compromise apoptotic body clearance. One possible mechanism is associated with decreased
activation of GTPase Rac1 which mediates actin reorganization and phagocytic cup formation for
effective dead cell engulfment [242].
Autophagy in adaptive immunity
Autophagy is also a cell biological pathway affecting adaptive immune responses. Studies
revealed that dendritic cells utilize autophagy machinery for optimal phagosome-to-lysosome
fusion and subsequent processing of antigen for MHC class II loading [243]. Another study
indicates that autophagy-dependent antigen presentation is defective in dendritic cells with Crohn's
disease-associated Atg16L1 risk variants [221].
In addition to its role in antigen presentation, autophagy affects both the homeostasis and
the functions of T cells. Autophagy and clearance of mitochondria are required for normal
haematopoietic stem cell maintenance and function [244]. After exiting the thymus, naive T cells
depend on autophagy and mitochondrial content reduction for their maturation [183]. Autophagy
also has a role in the selection of naive T cell repertoires in the thymus. Thymic epithelial cells
had a high level of constitutive autophagy. Atg5 deficiency in thymic epithelial cells led to altered
selection of MHC-II-restricted T-cell specificities and resulted in severe colitis and multi-organ
inflammation. These effects have been attributed to the defective presentation of cytoplasmic
antigens by autophagy-deficient thymic epithelial cells [184]. Autophagy is also involved in the
NF-κB activation in antigen-activated T cells. The adaptor protein Bcl-10 is a mediator of T cell
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receptor (TCR)/NF-κB signaling. TCR activation promotes K63 polyubiquitination of Bcl-10,
followed by Bcl-10 association with the autophagy adaptor p62. p62 binding was required for both
Bcl-10 signaling to NF-κB and gradual degradation of Bcl-10 by autophagy. The blockade of Bcl10 degradation via autophagy can enhance TCR activation of NF-κB. Hence, selective autophagy
is involved in the degradation of Bcl-10, which can reduce NF-κB activation by TCR in antigenactivated T cells [245].
Autophagy is required for plasma cell homeostasis and long-lived humoral immunity. Mice
with conditional deficiency of Atg5 in B cells showed plasma cells had a larger ER and more ER
stress signaling which led to more antibody secretion and fewer antigen-specific long-lived bone
marrow plasma cells. The enhanced antibody synthesis was associated with lower level of
intracellular ATP and more death of mutant plasma cells. Autophagy reduces immunoglobulin
secretion from plasma cells, which seems to be a mechanism preventing excessive antibody
production [246].
Autophagy and inflammatory disease
Perturbations in autophagy-dependent functions in immunity contribute not only to
increased susceptibility to infection, but also to chronic inflammatory diseases and autoimmune
diseases. The well-characterized link between autophagy and inflammatory disease is the
variations in autophagy proteins in association with Crohn's disease, a chronic inflammatory
disorder of the intestine [247]. Other emerging associations include the autoimmune diseases such
as systemic lupus erythematosus (SLE) [248] , and inflammation-associated metabolic disorders
such as obesity and diabetes [249, 250].
Genome-wide association studies identified that Crohn's disease susceptibility genes, such
as Atg16L1, are involved in autophagy [247]. Antigen presentation has been found defective in
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dendritic cells from patients with the Crohn's disease-associated Atg16L1 risk variant [221].
Studies using mouse model with Atg16L1 mutation further proved that defective autophagy is
relevant to pathogenesis of Crohn's disease. Loss of Atg16l1 function in mice results in enhanced
proinflammatory cytokine production by macrophages induced by TLR agonists [199], enhanced
chemical-induced colitis [199, 251] and altered inflammatory gene transcriptional profiles in
Paneth cells [205, 251].
Genome-wide association studies have also linked several single nucleotide
polymorphisms in Atg5 to SLE susceptibility [248, 252, 253]. SLE is characterized by
autoimmune responses against self-antigens. Autophagy protein Atg5 is critical for T-cell selection
which is responsible for the generation of a self-tolerant T-cell repertoire in thymus. Atg5-depleted
thymic epithelial cells are defective in negative thymic selection, resulting in generation of
autoimmunity and multi-organ inflammation in mice [184]. Other Atg5-dependent effects,
including regulation of IFN and proinflammatory cytokine secretion [233, 254], clearance of dying
cells [254] and dendritic cell antigen presentation [243], might also be relevant to the
autoimmunity and inflammation associated with SLE.
Defects in autophagy may contribute to some metabolic diseases, such as diabetes and
obesity, which are linked to inflammation and insulin resistance [255]. Hepatic suppression of
Atg7 in mice results in increased ER stress and insulin resistance [249]. p62 deficient mice
develop mature-onset obesity and insulin resistance [250]. Thus, the defective autophagydependent regulation of ER stress, as well as immune cell homeostasis and activation may
contribute to inflammatory responses that underlie the pathogenesis of metabolic diseases [196].
1.4 p120 Catenin in inflammation
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The evidence that p120ctn might be involved in the regulation of inflammation was first
observed in p120ctn knockout animal models. Conditional knockout of p120ctn in mice results
in a chronic inflammatory response in intestines [256, 257] and epidermis [258, 259], which
is characterized by tissue infiltration of immune cells including lymphocytes, mast cells,
granulocytes, and macrophages, as well as expression of pro-inflammatory cytokines, such as
TNF-α, IL-1β, IL-6, macrophage inflammatory protein 3 α (MIP3α), and macrophage chemotactic
protein 1 (MCP1), even in the absence of exogenous inflammatory stimuli. In human endothelial
cells, depletion of p120ctn increased transcription factor activities (including NF-κB, AP-1, and
Kaiso),

adhesion

molecules

expression,

neutrophil

adhesion,

and

Erk1/2

signaling

[260]. Overexpression of p120ctn in human umbilical vein and dermal microvascular endothelial
cells inhibited neutrophil transendothelial migration [261]. p120ctn-depleted epidermal cells have
elevated activities of NF-κB, which triggers a cascade of proinflammatory responses both in
vivo and in vitro. The activation of RhoA/Rho-associated protein kinase (ROCK) pathway
resulting from the loss of p120ctn might be partially responsible for NF-κB over-activation and
proinflammatory cytokine production [259]. There is also a significant correlation between
p120ctn loss and increased incidence of inflammatory bowel disease in both human patients and
mouse models [257, 262]. Multiple researches demonstrated that p120ctn depletion could cause a
chronic inflammatory response which might be mediated by the mechanism that does not require
some specific exogenous stimuli under some circumstances.
Immune functions of p120 catenin in LPS/TLR4-dependent inflammatory response
p120ctn knockdown alone in mouse lung endothelial cells did not significantly affect NFκB activation but enhanced LPS-induced NF-κB activation, which suggests an important role of
endothelial p120ctn in the regulation of LPS/TLR4-dependent NF-κB signaling. In LPS-induced
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lung injury mouse model, p120ctn was rapidly degraded in response to LPS challenge. Moreover,
the level of p120ctn was correlated inversely with the severity of lung inflammation. Hence,
endothelial p120ctn degradation during endotoxemia might be one of the reasons for the
amplification of pulmonary inflammation. Depletion of p120ctn in pulmonary endothelial cells
could increase the sensitivity to LPS and induced inflammatory response characterized by
increased production of proinflammatory cytokines (such as TNF-α and IL-6), elevated neutrophil
infiltration into the lung, hyperpermeability of pulmonary vasculature. In contrast, overexpression
of p120ctn could suppress those LPS-induced effects [263]. Hyperpermeability of pulmonary
vasculature induced by LPS might be associated with LPS-induced tyrosine phosphorylation of
VE-cadherin, γ-catenin, and p120ctn through Src family tyrosine kinases [264]. Therefore,
endothelial p120ctn may be a negative regulator of sepsis-induced lung inflammatory injury.
p120ctn can also regulate LPS/TLR4 signaling by facilitating TLR4 endocytic trafficking
in mouse bone marrow-derived macrophages. p120ctn silencing could diminish LPS-induced
TLR4 internalization. Genetic and pharmacological inhibition of RhoA could rescue the decrease
in endocytosis of TLR4 and TLR4-MyD88 signaling in p120ctn null cells. This might be another
reason for LPS-induced over-inflammatory response in p120ctn-depleted cells [265].
p120 Catenin regulating inflammation via RhoA/ROCK-dependent signaling
RhoA/ROCK signaling associates with the activation of IKK/NF-κB [266, 267]. Since
cytosol p120ctn can interact with RhoA and inhibit its activation, RhoA/ROCK pathway would be
one of the mechanism to explain how p120ctn regulates NF-κB-mediated inflammatory response.
In mouse p120ctn-depleted epidermis, chronic inflammation and increased NF-κB activity were
observed even without specific stimuli [259]. Re-expression of wild-type p120ctn, overexpression
of dominant-negative RhoA or inhibition of ROCK reduced NF-κB activity. In contrast,
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expression of a mutant form of p120ctn (Δ622–628) which is unable to bind to RhoA failed to
suppress NF-κB activity. Expression of a cadherin-uncoupled p120ctn mutant in keratinocytes still
could reduce NF-κB activity, suggesting that cadherin binding is not required for the ability of
p120ctn to inhibit NF-κB activity in human epidermis [259].
1.5 Hypotheses of this study
p120 Catenin suppresses LPS-induced inflammatory response via its inhibitory effects on
NF-κB pathway activation in THP-1 derived macrophages. Decreased autophagy is associated
with abnormal proinflammatory reactions in p120 catenin-depleted macrophages in response to
LPS stimulation.
1.6 Specific aims of this study:
1. To examine the expression of p120 catenin in THP-1 derived macrophages in response to
LPS challenge.
2. To study the functions of p120 catenin in NF-κB signaling in THP-1 derived macrophages
in response to LPS challenge.
3. To investigate the effects of p120 catenin depletion on LPS-induced autophagy in THP-1
derived macrophages.
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CHAPTER 2 MATERIALS AND METHODS
2.1 Antibodies and reagents
Anti-human p120 catenin (G7) (targeting N-terminus) and Na+/K+ ATPase antibodies
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA); Antibodies including
anti-phosphorylated and total Erk, p38, JNK, Akt, Src, IKK, and NF-κB p65 were from Cell
Signaling Tecnology (Danvers, MA, USA). Anti-IκBα, LC3, Atg3, Atg7, Atg12, Atg16L1 and
lamin B1 antibodies were purchased from Cell Signaling Tecnology (Danvers, MA, USA).
Anti-p62 antibody was acquired from Abcam (Cambridge, MA, USA). Anti-GAPDH
antibody, M-PER protein extraction reagent and subcellular protein fractionation kit were
purchased from Thermo Fisher Scientific (Waltham, MA, USA). RPMI 1640 media, HEPES
and fetal bovine serum (FBS) were obtained from Thermo Scientific HyClone (Logan, UT,
USA). LPS (Escherichia coli, O111:B4, and Pseudomonas aeruginosa 10), phorbol 12myristate 13-acetate (PMA) and MG132, goat serum were acquired from Sigma-Aldrich (St.
Louis, MO. USA). Bafilomycin A1 was acquired from Cell Signaling Tecnology (Danvers,
MA, USA). PP2 was purchased from Cayman (Ann Arbor, MI, USA). Lentivirus p120ctn
shRNA and control shRNA were purchased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). PCR primers for cytokines and p120ctn isoforms were synthesized by Sigma-Aldrich
(St. Louis, MO. USA). ReliaPrep™ RNA Cell Miniprep System was from Promega (Madison,
WI, USA). ProtoScript II reverse transcriptase, murine RNase inhibitor, dNTP mix and
TopTaq DNA polymerase were from New England Biolabs (Ipswich, MA, USA). Laemmli
sample buffer and Clarity Western ECL reagents were purchased from Bio-Rad Life Science
(Hercules, CA, USA).
2.2 Cell culture
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Human monocytic THP-1 cells were obtained from the ATCC (TIB-202TM). THP-1 cells
were cultured in RPMI 1640 medium containing 10% of FBS, 10 mM HEPES, 50 µM ßmercaptoethanol, 100 U/ml penicillin and 100 μg/ml streptomycin. THP-1 monocytes were
differentiated into THP-1 derived macrophages (TDMs) by culturing with 10 ng/ml phorbol 12myristate 13-acetate (PMA) in RPMI 1640 medium containing 10% of FBS and 10 mM HEPES
for 3 days. TDMs were then treated with other reagents after cultured in RPMI 1640 medium
without PMA overnight. Lung cancer cell lines A549 and Calu-3 cells were from ATCC. A549
cells were cultured in RPMI 1640 medium containing 10% of FBS, 100 U/ml penicillin and 100
μg/ml streptomycin. Calu-3 cells were cultured in DMEM/F12 medium containing 10% of FBS,
100 U/ml penicillin and 100 μg/ml streptomycin.
2.3 p120 Catenin knockdown inTHP-1 cells
Lentivirus p120ctn shRNA and control shRNA were used to knock down p120ctn
expression in THP-1 cells. Stable p120ctn knockdown THP-1 cell line was selected with 1 μg/ml
puromycin for 3 days. p120ctn knockdown THP-1 cells were further differentiated to macrophages
with PMA. The expression of p120ctn was tested via PCR and Western blot.
2.4 Western blot
Culture cells were lysed with M-PER protein extraction reagent after washed with cold
PBS twice. The total proteins were resolved by SDS-PAGE, followed by transfer to polyvinylidene
fluoride membranes. The membranes were then blocked with 1% goat serum, followed by
overnight incubation with antibodies anti-target proteins at 4°C and then with goat antimouse/rabbit IgG at room temperature for 1 hour. The protein bands were visualized by using
Clarity Western ECL reagents.
2.5 p120 Catenin isoform identification
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p120ctn isoforms were identified via reverse transcription PCR (RT-PCR) and Western
blot. Total RNA was isolated from the cells using ReliaPrep™ RNA Cell Miniprep System, in
accordance with the manufacturer’s recommendations. The total RNA was then synthesized to
cDNA by reverse-transcription. PCR was used to identify the isoforms of p120ctn expressed in
THP-1 and THP-1 derived macrophages by using specific primers targeting different mRNA
variants. The primers and the PCR conditions were described previously (Table 2.1) [268].
GAPDH was used as internal control. The products were analyzed on a 1-2% agarose gel and
compared to a 100 bp DNA ladder. The protein expression was analyzed using Western blot.
Epithelial cells A549 and Calu3 were used as control.
2.6 Expression and distribution of p120ctn in macrophages upon LPS stimulation.
TDMs were stimulated with LPS (both E. coli and P. aeruginosa) in RPMI 1640 medium
containing 5% of FBS and 10 mM HEPES for indicated time points. Total protein was extracted
with M-PER protein extraction reagent. Subcellular proteins, including membrane, cytosolic and
nuclear protein, were prepared by using Subcellular protein fractionation kit. Western Blot was
then used to test the total expression and subcellular localization of p120ctn in macrophages upon
LPS stimulation for indicated time intervals. Relative protein levels were compared in reference
to internal controls including Na+/K+ ATPase, GAPDH, and lamin B1. The macrophages were
pretreated with Src inhibitor PP2 (10 μM) for 30 minutes, followed by stimulation with 1 μg/ml of
LPS (E. coli O111:B4) for 2 hours. The total p120ctn expression was tested via immunoblot. To
test the pathways responsible for p120ctn degradation, the macrophages were stimulated with 1
μg/ml of LPS (E. coli O111:B4) for 30 min, followed by treatment with or without bafilomycin
A1 (1 μM) or MG132 (10 μM) for 2 hours (LPS was not removed). The total p120ctn expression
was tested via immunoblot.
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2.7 Analysis of proinflammatory cytokine expression
p120ctn knockdown and control macrophages were stimulated by 100 ng/ml of LPS in
RPMI1640 medium containing 5% FBS for indicated time. Proinflammatory cytokines (IL-1β, IL8, IL-6 and TNF-α) were examined by RT-PCR. PCR primers and conditions were described in
Table 2.2.
2.8 Activation of signaling pathways
Macrophages were cultured in RPMI 1640 medium containing 1% FBS overnight,
followed by stimulation with LPS for indicated time. Activation of signaling pathways, including
NF-κB, MAPK, Src and Akt pathways, was investigated by immunoblot.
2.9 LPS-induced autophagy
THP-1 derived macrophages were stimulated with 100 ng/ml of LPS (E. coli, O111:B4) in
RPMI1640 medium containing 5% FBS for indicated time. LC3, P62 and Atgs were tested by
Western blot. In order to test autophagy flux, the macrophages were stimulated with 100 ng/ml of
LPS (E. coli O111:B4) for 8 hours, followed by treatment with or without bafilomycin A1 (1 μM)
for 1 hour. LC3 and p62 were tested by Western blot.
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CHAPTER 3 RESULTS
3.1 Establishment of macrophage cell model.
THP-1 cells, a human monocytic cell line, were induced to differentiate into THP-1 derived
macrophages after exposure to PMA for 3 days. During the differentiation, suspension THP-1
monocytes adhered to culture plates accompanied by differentiating into a macrophage phenotype:
flat, spreading and amoeboid in shape (Figure 3.1A). Prior to examing p120 catenin functions,
THP-1 derived macrophages were stimulated with 1 μg/ml of LPS (P. aeruginosa 10) for 12 and
24 hours. mRNA expression of proinflammatory cytokines including IL-1β, IL-8 and TNF-α was
tested via RT-PCR. mRNA level of IL-1β, IL-8 and TNF-α was significantly increased in
macrophages upon LPS stimulation (Figure 3.1B).
3.2 p120 Catenin isoforms in macrophages
p120ctn has multiple isoforms due to alternative splicing. In order to identify the isoforms
expressed in THP-1 monocytes and mcrophages, RT-PCR was used to analyze the mRNA
expression of p120ctn isoforms, using specific primers targeting different mRNA variants of
isoforms. Lung cancer cell lines A549 and Calu-3 were used as control. In combination with the
protein bands analyzed via Western blot, THP-1, THP-1 derived macrophages, and A549 expressd
isoform 1A and 3A, whereas Calu-3 expressed isoform 3A and 3AB. The protein levels of two
isoforms were similar in macrophages (Figure 3.2 and Table 3.1 ).
3.3 p120 Catenin expression in macrophages in response to LPS stimulation.
The expression of p120 catenin in THP-1 derived macrophages was determined by Western
blot analysis following stimulation of LPS. p120ctn protein level was reduced in a time-dependent
manner following E. coli LPS challenge, whereas p120ctn expression in macrophages was not
changed significantly after P. aeruginosa LPS stimulation (Figure 3.3A). p120ctn decreased to the
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lowest level within 4-hour treatment of LPS from E. coli and then gradually recovered within 24
hours after LPS exposure (1 g/ml). The effects of LPS (E. coli) on p120ctn mRNA expression
was examined by RT-PCR and no significant difference was observed (Fig. 3.3B). These results
suggest that the rapid loss of p120ctn after LPS (E. coli) challenge might be due to the enhanced
degradation of p120ctn protein. Next, the proteasome inhibitor MG132 and autophagy inhibitor
bafilomycin A1 were used to identify the pathways for degradation of p120ctn protein in
macrophages following LPS challenge. The loss of p120ctn protein following LPS treatment was
not suppressed in macrophages after inhibition of proteasomal pathway, whereas p120ctn
degradation after LPS stimulation was inhibited by autophagy inhibitor bafilomycin A1. Thus
these results indicate that the autophagic pathway might be the major mechanism responsible for
p120ctn protein degradation in macrophages following E. coli LPS challenge (Fig. 3.3C). The total
protein of p120ctn was not significantly changed in macrophages after stimulation with P.
aeruginosa LPS. Therefore, the subcellular distribution of p120ctn protein was analyzed and no
significant change was observed in macrophages after P. aeruginosa LPS treatment (Figure 3.3D).
3.4 Activation of MAPK and NF-B signaling pathways in THP-1 derived macrophages after
LPS treatment.
Since LPS from E. coli and P. aeruginosa could induce different effects on p120ctn protein
expression in macrophage, the signaling pathways were compared in macrophages upon both LPS
(1 g/ml) stimulation. Both LPS could activate MAPK pathways including Erk, p38 and JNK, and
no significant difference was observed in the activation pattern of these signaling pathways in
macrophages after both LPS stimulation (Figure 3.4, A and B). The basal level of activated Akt
was very high and the activation of Akt was not very strong in THP-1 derived macrophages
following stimulation of LPS from both E. coli and P. aeruginosa (Figure3.4, A and B). The
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activation of NF-B signaling pathway was also examined in macrophages upon LPS stimulation.
As the Figure 3.4, C and D showed, the time-dependent pattern of IKK activation and IB
degradation was similar in macrophages after treatment with LPS from both E. coli and P.
aeruginosa.
3.5 Src signaling responsible for the degradation of p120 catenin in THP-1 derived
macrophages upon LPS stimulation
There are two major phosphorylation sites on Src: Tyr416 and Tyr527. Tyr416
phosphorylation activates Src by allowing the substrate to gain access to the catalytic domain.
Phosphorylation of Tyr527 inactivates Src through changing Src conformation into a closed
inaccessible bundle [269]. Upon E. coli LPS stimulation, Src was phosphorylated at Tyr416
(Figure 3.5B), whereas the phosphorylation of Src Tyr416 was not observed in macrophage after
P. aeruginosa LPS challenge (Figure 3.5A). The phosphorylated state of Src at Tyr527 was not
changed in macrophages after the stimulation by LPS from both E.coli and P. aeruginosa. These
data indicated that Src signaling might be responsible for protein degradation of p120ctn in
macrophages upon LPS stimulation. In order to test this hypothesis, PP2, an inhibitor for Srcfamily kinases, was used to pretreat the macrophages, followed by stimulation of E. coli LPS. As
Figure 3.5C displayed, PP2 could partially inhibit the downregulation of p120ctn in response to
LPS challenge.
3.6 mRNA expression of proinflammatory cytokines in p120 catenin knockdown
macrophages in response to LPS stimulation.
To study the effects of p120ctn ablation on inflammation in macrophages, p120ctn
knockdown THP-1 cell line was generated by transduction of cells with p120ctn-specific short
hairpin RNA (shRNA). Random shRNA was used as control. p120ctn knockdown in THP-1 cell
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line was verified via RT-PCR and Western blot. PCR and Western blot analyses revealed a
dramatic reduction of both mRNA and protein levels of p120ctn compared with shRNA control
cells (Figure 3.6). As expected, p120ctn loss led to an increase in mRNA levels of proinflammatory
cytokines in macrophages upon LPS treatment, especially within 8 hours after LPS stimulation.
The effects of p120ctn ablation on mRNA expressions of IL-1β, IL-8 and TNF-α were similar in
macrophages stimulated by LPS from both E. coli and P. aeruginosa. p120ctn loss resulted in an
upregulation of IL-6 expression in macrophages after E. coli LPS stimulation. However, P.
aeruginosa LPS did not induce significant expression of IL-6 mRNA in THP-1 derived
macrophages despite the loss of p120ctn (Figure 3.7).
3.7 NF-κB signaling in p120 catenin knockdown macrophages in response to LPS challenge
NF-κB is the master transcription factor for expression of proinflammatory cytokines in
cells in response to LPS stimulation. Upon stimulation of LPS, IKKγ was phosphorylated and
activated more rapidly in p120ctn knockdown macrophages (within 10 minutes), as compared with
shRNA control cells. However, the loss of p120ctn did not increase the period of IKKγ activation.
(Figure 3.8A). No significant differences were observed in IκBα degradation within 30 minutes
after LPS stimulation in p120ctn knockdown macrophages as compared with control cells. (Figure
3.8A). The nuclear translocation of NF-κB p65 was not significantly changed by the loss of
p120ctn in macrophages upon LPS stimulation. The phosphorylation of nuclear NF-κB p65 at
Ser536 in p120ctn knockdown macrophages seemed augmented within one hour after LPS
treatment (Figure 3.8, B and C).
3.8 Loss of p120 catenin decreases LPS-induced autophagy in THP-1 derived macrophages
Western blot analysis of p62 and LC3 was used to monitor the levels of autophagy. When
autophagy is induced, LC3-I is conjugated to PE to form LC3-II, which is recruited to the
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phagophore. p62 delivers ubiquitinated proteins to the autophagosome and itself is degraded in the
lysosome. LPS (E. coli) could induce autophagy in both p120ctn knockdown and shRNA control
macrophages (Figure 3.9A). The decreased basal level of p62 was observed in p120ctn knockdown
macrophages as compared with shRNA control macrophages without LPS treatment. Upon
stimulation of LPS, p62 was decreased in control macrophages for a short period (within 60
minutes), followed by upregulated expression. In p120ctn knockdown macrophages, LPS induced
time-dependent upregulation in p62 protein expression, and degradation of p62 was not significant
(Figure 3.9B). In order to compare the difference of the autophagy flux in p120ctn knockdown
and shRNA control macrophages, an inhibitor bafilomycin A1 was used to block the autophagy.
Bafilomycin A1 blocks maturation of autolysosome by inhibiting fusion of autophagosomes with
lysosomes [270]. Macrophages was stimulated by LPS for 8 hours followed by treatment of
bafilomycin A1 for another 1 hour. The decreased level of LC3-I and LC3-II was observed in
p120ctn knockdown cells compared with shRNA control macrophages (Figure 3.9C). The change
of p62 protein level was not observed in both p120ctn knockdown and control cells in response to
inhibition of autophagy (Figure 3.9D).
3.9 Autophagy-associated protein expression in p120 catenin knockdown macrophages in
response to LPS challenge
The process of LC3-I to LC3-II is regulated by several autophagy-associated proteins. The
macrophages were stimulated by LPS for indicated time and Atg protein level was tested by
Western blot. The protein level of Atg3, Atg7 and Atg16L1was not changed in both p120ctn
knockdown and control macrophages upon LPS challenge (Figure 3.10, A, B and C). Conjugated
Atg12-Atg5 was gradually downregulated 8 hours after LPS stimulation (Figure 3.10 D).
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Table 2.1. Primers used to identify p120ctn isoforms [268]
Primers

Sequence 5’→3’

Total p120ctn:

CAGCATGAGCGAGGAAGTTT
ATGGCGTGGCTTACAGTCTT

55

540

Isoforms 1, 2, 3:

TGCCCTGCTGGATTTGTCTT
CGAGTGGTCCCATCATCTG

56

705 (1), 477 (2),
225/297/319/369 (3)

Isoforms A, B:

AAACCTGATCGGGAAGAAAT
ACTGGCAAAAAGAACTAATC

52

470 (A), 557 (B)

Isoform C:

TTGCCTTCTTCGGAACTTAT
CACTGTATCGTTTGCTGGAT

52

193

GAPDH

ATCTTCCAGGAGCGAGATC
ACCACTGACACGTTGGCAGT

58

503

Tm (℃) Fragment size (bp)
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Table 2.2. Primers used to examine cytokine expression
Primers

Sequence 5’→3’

IL-1β

ACGCTCCGGGACTCACAGCAA
TTGAGGCCCAAGGCCACAGGTATT

58

164

IL-8

CGTGGCTCTCTTGGCAGCCTTC
TTTCTGTGTTGGCGCAGTGTGGTC

58

179

IL-6

CAATGAGGAGACTTGCCTGGTG
GGTTGGGTCAGGGGTGGTTA

52

193

TNF-α

GCTGCACTTTGGAGTGATCG
GCTTGAGGGTTTGCTACAACA

52

144

GAPDH

ATCTTCCAGGAGCGAGATC
ACCACTGACACGTTGGCAGT

58

503

Tm (℃) Fragment size (bp)
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Table 3.1. The p120 catenin isoforms expressed in various cell lines
Cell line

Isoforms

Length (aa)

MW (kD)

THP-1

1A, 3A

933, 832

104, 93

THP-1 derived macrophage

1A, 3A

933, 832

104, 93

A549

1A, 3A

933, 832

104, 93

Calu3

3A, 3AB

832, 861

93, 96
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Figure 1.1. Candherin/catenin complex. The extracellular domain of cadherin interacts in a
homophilic fashion to form adherens junction between adjacent cells. Cadherin function is
modulated by a group of catenins. β-Catenin binds to the catenin-binding domain of cadherin and
functionally links cadherin with the actin cytoskeleton through α-catenin, while p120ctn is
responsible for stabilizing cadherin-catenin complexes at the cell surface by interacting with the
juxtamembrane domain of cadherin.
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Figure 1.2. Schematic representation of human p120 catenin isoforms. Multiple isoforms of
p120ctn result from the use of alternative start codons (M) and alternative splicing exons A (880900, 21aa), B (937-965, 29aa) and C (626-631, 6aa). Sizes are indicated in amino acid residues
(aa). Arm 6: 583-624aa. M: Methionine start codons. CCD: coiled coil domain (10-46, 37aa). RD:
regulatory domain. This figure was sketched based on the information from Uniprot (UniProtKB O60716 CTND1_HUMAN).
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Figure 1.3. Toll-like receptor 4 (TLR4) signaling. TLR4 initiates intracellular signaling by at
least two major pathways: (1) MyD88-dependent/TIRAP–MyD88 pathway.TLR4 signals through
the key adaptors MyD88/TIRAP to recruit downstream kinase IRAK. Activated IRAK then
associates with TRAF6, resulting in the activation of two signaling pathways. One pathway leads
to activation of transcription factor AP-1 through MAPK activation cascade. Another pathway
activates IKK complex, leading to nuclear translocation of transcription factor NF-κB. MyD88depedent pathway regulates the production of inflammatory cytokines, such as IL-1 and IL-12. (2)
MyD88-independent TRIF–TRAM pathway, which activates IRF3 transcription factor, leading to
the subsequent expression of the type I IFN.
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Figure 1.4. The process of macroautophagy in mammalian cells. A portion of cytoplasm is
enclosed by an isolation membrane (phagophore) to form an autophagosome. The outer membrane
of the autophagosome subsequently fuses with the lysosome, and the internal material is degraded.
The nomenclature for various autophagic structures and stages of autophagy are indicated.
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A

B

Figure 1.5. Two protein conjugation systems required for autophagosome formation. Atg12
is covalently conjugated to Atg5 in a process assisted by the enzymes Atg7 and Atg10. Atg12–
Atg5 conjugates form a complex with Atg16L1 (Atg12-Atg5-Atg16L1 complex). Pro-LC3 is first
cleaved by Atg4 at the carboxyl terminus to expose a glycine residue. Then LC3-I is ligated to the
lipid phosphatidylethanolamine (PE) to form LC3-II in the process assisted by Atg7, Atg3 and
Atg12-Atg5-Atg16L1 complex.
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A
B

Figure 3.1. THP-1 cells were induced to differentiate into macrophages (THP-1 derived
macrophages). (A). The human monocytic cell line THP-1 cells were differentiated into THP-1
derived macrophages by culturing with PMA (10 ng/ml) for 3 days. The morphology of monocytic
cell THP-1 and macrophages was analysed by microscope. (B). THP-1 derived macrophages were
stimulated with LPS from Pseudomonus aeruginosa 10 (1 μg/ml) for 12 hours and 24 hours. The
mRNA expression of pro-inflammatory cytokines including IL-1α, IL-8 and TNF-α was tested via
reverse transcription PCR.
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A

B

D

C

E

Figure 3.2. p120 Catenin isoform expression in THP-1 cells and THP-1 derived macrophages.
mRNA expression of p120ctn isoforms 1, 2 and 3 (A), isoforms A and B (B), as well as isoforms
C (C) was analyzed by RT-PCR in THP-1 cells, THP-1 derived macrophages (TDM), and lung
cancer cell lines including A549 and Calu-3. The total mRNA expression (D) and protein
expression (E) of p120ctn were tested in those four cell lines. The isoform codes and their fragment
sizes are depicted.
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A

B

C

D

Figure 3.3. p120 Catenin expression in THP-1 derived macrophages in response to LPS
stimulation. (A). THP-1 derived macrophages were stimulated with 1 μg/ml of LPS from E. coli
and P. aeruginosa for indicated time intervals. Total expression of p120ctn was analyzed via
Western blot. (B). mRNA expression of p120ctn was tested via RT-PCR in macrophages after
treatment with 1 μg/ml of LPS (E. coli). (C). p120ctn degradation was inhibited by autophagy
inhibitor bafilomycin A1 in macrophages in response to the stimulation of 1 μg/ml of LPS from
E. coli. (D). Subcellular distribution of p120ctn was analyzed in THP-1 derived macrophages after
stimulation with 1 μg/ml of LPS from P. aeruginosa.
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A

B

C

D

Fig 3.4. Comparison of TLR4 signaling in THP-1 derived macrophages in response to the
stimulation of LPS from E. coli and P. aeruginosa. Western blot analysis of MAPK and Akt
signaling in macrophages upon stimulation of LPS (1 μg/ml) from P. aeruginosa (A) and E. coli
(B). NF-κB signaling was compared in macrophages after stimulation with P. aeruginosa LPS (C)
and E. coli LPS (D)
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A

B

C

Fig 3.5. Signaling of tyrosine kinase Src associated with downregulation of p120 catenin in
THP-1 derived macrophages after LPS (E. coli) stimulation. Src activation was analyzed in
macrophages after treatment with P. aeruginosa LPS (A) and E. coli LPS (B). (C). Macrophages
were pretreated with Src inhibitor PP2 (10 μM) for 30 minutes, followed by stimulation of 1 μg/ml
of LPS (E. coli) for 2 hours. p120ctn expression level was examined by Western blot.
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A

B

Figure 3.6. Verification of p120 catenin knockdown in THP-1 derived macrophages. shRNA
lentivirus targeting p120ctn was used to knock down the expression of p120ctn in THP-1 derived
macrophages. The mRNA level (A) and protein expression (B) of p120ctn were tested after shRNA
transfection.
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A

B

Figure 3.7. mRNA expression of proinflammatory cytokines in p120 catenin knockdown
macrophages in response to LPS stimulation. The mRNA expression of proinflammatory
cytokines, including IL-1β, IL-8, TNF-α and IL-6, was analyzed via RT-PCR in p120ctnknockdown and shRNA control macrophages upon stimulation of LPS (100 ng/ml) from P.
aeruginosa (A) and E. coli (B).
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A

B

C

Figure 3.8. NF-κB signaling in p120 catenin knockdown macrophages in response to LPS (P.
aeruginosa) stimulation. (A). The phosphorylation of IKKβ and degradation of IκBα were
detected via Western blot in p120ctn-knockdown and shRNA control macrophages upon
stimulation of LPS. After stimulation of LPS in p120ctn-knockdown and shRNA control
macrophages, the translocation and phosphorylation NF-κB p65 at Ser536 (B) and (C) was
analyzed by western blot. GAPDH and Lamin B1 were used as cytoplasmic and nulcear internal
controls respectively.
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Figure 3.9. LPS-induced autophagy in p120 catenin knockdown THP-1 derived
macrophages. p120ctn-knockdown and shRNA control macrophages were treated with 100 ng/ml
of LPS (E. coli) for indicated time. Autophagy was tested by Western blot analysis of LC3 (A) and
p62 (B). The macrophages were stimulated with 100 ng/ml of LPS (E. coli) for 8 hours, followed
by treatment with autophagy inhibitor bafilomycin A1 (1μM) (DMSO as vehicle control) for 1
hour. LC3 (C) and p62 (D) was then analyzed by Western blot.
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Figure 3.10 Expression of autophagy-associated proteins Atgs in p120 catenin knockdown
THP-1 derived macrophages after LPS treatment. p120ctn-knockdown and shRNA control
macrophages were treated with 100 ng/ml of LPS (E. coli) for indicated time. Autophagyassociated proteins including Atg3 (A), Atg7 (B), Atg16L1 (C) and conjugated Atg12-Atg5 (D)
were compared between p120ctn-knockdown macrophages and shRNA control macrophages by
Western blot.
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CHAPTER 4 DISCUSSION, CONCLUSIONS AND FUTURE DIRECTIONS
4.1 Discussion
The incidence of severe sepsis is estimated to be 300 cases per 100,000 population in the
United States [271]. European Prevalence of Infection in Intensive Care (EPIC II) study reported
that the predominant organisms were Staphylococcus aureus (20.5%), Pseudomonas species
(19.9%), Enterobacteriaceae (mainly E. coli, 16.0%), and fungi (19%), with Gram-negative
organisms being still prevalent [272]. Sepsis associated with Gram-negative bacteria is a persistent
problem all over the world. In spite of the development of new antibiotics, mortality from Gramnegative bacteria sepsis remains very high [273]. The outer membrane component of Gramnegative bacterial, LPS, is recognized as the most potent microbial mediator implicated in the
pathogenesis of sepsis and septic shock [274]. The levels of circulating LPS can predict
development of multi-organ failure, including acute respiratory distress syndrome [275]. LPS as a
component of Gram-negative bacterial membrane has been used as a model representing Gramnegative bacteria-induced inflammation [276, 277]. In order to study the effects of p120ctn on
inflammatory reactions in macrophages, LPS was used to stimulate macrophages in my studies.
Cell model for studying human p120 catenin functions in macrophages
There are several cell models for studying human macrophage, such as THP-1, U937, and
HL-60. THP-1 cell line was established from the peripheral blood of a 1-year old male patient with
acute monocytic leukemia [278]. This cell line has been widely used to study immune responses
in the monocyte state and in the macrophage-like state [279, 280]. THP-1 cells can be
differentiated into a macrophage-like phenotype by using either PMA, or 1α, 25-dihydroxyvitamin
D3 (Vit D3) [279]. Vit D3-induced differentiation of THP-1 cells resulted in macrophages less
similar to human monocyte derived macrophages in terms of phagocytic activity and production
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of IL-1β and TNF-α, as compared with THP-1 derived macrophages generated by using PMA
[279]. Compared with heterogeneous PBMC monocytes from individual donors, the homogeneous
genetic background of THP-1 could minimize the degree of phenotype variability, which facilitates
reproducibility of studies. Moreover, PBMC monocytes require cytokines, such as IL-1β or TNFα, granulocyte-monocyte-colony stimulating factor or IFN-γ to function as survival factors to
prevent apoptosis, whereas, THP-1 cells can be easily cultured, as well as be stocked in liquid
nitrogen [281, 282]. Therefore, THP-1 cell line is the optimal monocyte model. PMA is the most
effective and universally used differentiation agent to acquire THP-1 derived macrophages with
similarities to human monocyte derived macrophages [281]. In my study, 10 ng/ml of PMA was
used to induce THP-1 cells to differentiate into macrophage-like cells. After 3-day culturing with
PMA, THP-1 monocytes acquired typical morphological features of macrophage: adhesive to
culturing plate and flatten into irregular and elongated cells with short protrusions. The production
of proinflammatory chemokines and cytokines was also used to identify one of the typical
functions of macrophages in response to LPS stimulation. As shown in Figure 3.1B, PMA-induced
THP-1 derived macrophages could respond to LPS challenge in terms of the proinflammatory
cytokine expression.
Isoforms of p120 catenin in THP-1 derived macrophages
Divergent expression patterns of p120ctn isoforms have been observed in a tissue- and celltype-specific manner [22, 283, 284]. The cell type-specific expression of p120ctn isoforms was
evident. The expression of p120ctn isoforms varies in abundance among different cell types [18].
It has been reported that the mesenchymal and motile cells, such as macrophages and fibroblasts,
express p120ctn long isoforms, whereas the epithelial or endothelial cells predominantly express
short isoforms [22]. In my study, the RT-PCR and Western blot analysis showed that both THP-1
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monocytes and THP-1 derived macrophages express p120ctn isoform 1A and 3A. Compared with
THP-1 monocytes, PMA-induced macrophages express higher level of p120ctn isoform 1A and
3A . The increased expression of p120ctn might be a marker for monocyte differentiation. But this
would require using multiple monocyte/macrophage cell models to figure out the PMA effect on
the expression of p120ctn. My study demonstrated that monocytes or macrophages could express
more than one isoforms, possibly both long isoform (isoform 1A) and short isoform (isoform 3A).
Moreover, the preferential expression of either isoform was not observed in THP-1 cells and THP1 derived macrophages at least by the antibody used in this study. However, the subcellular
distribution of p120ctn showed that the membrane would predominantly express the short isoform
3A, and no significant difference of isoform expression was observed in cytoplasmic and nuclear
part in macrophages (Figure 3.3D). It has been reported that in tumor cell lines, p120ctn isoform
1A promoted the epithelial mesenchymal transition (EMT) and increased tumor cell invasiveness,
while p120ctn isoform 3A showed the opposite effects on EMT and invasiveness [285]. But the
functions of different p120ctn isoforms have not been very clear in macrophages. In addition, the
profile of p120ctn isoform expression was not switched by LPS challenge (Figure 3.3A). p120ctn
isoform 4 is rarely expressed as a protein [17], so this study didn’t examine the expression of
isoform 4 in macrophages.
LPS-induced degradation of p120 catenin in THP-1 derived macrophages
Previous study revealed that LPS challenge could reduce p120ctn protein expression in
mouse lungs and pulmonary endothelial cells [263]. The p120ctn protein level was correlated
inversely with severity of lung inflammation. Knockdown of p120ctn also increased the neutrophil
recruitment, production of cytokines TNF-α and IL-6, and pulmonary transvascular permeability
in response to LPS [263]. p120ctn expression was also observed to be significantly reduced after
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LPS stimulation in human bronchial epithelial cell line [286]. My research revealed that P.
aeruginosa LPS could not induce p120ctn downregulation or redistribution in macrophages,
whereas E. coli LPS reduced the p120ctn expression in macrophages within 4 hours after LPS
treatment. Moreover, the mRNA expression level of p120ctn was not decreased by E. coli LPS
stimulation, which indicated that the decreased protein level was not attributed to reduced mRNA
level of p120ctn. Next, the pathways responsible for p120ctn degradation were analyzed by using
inhibitors targeting proteasome and autophagy respectively. As shown in Figure 3.3C, autophagy
inhibitor bafilomycin A1, but not proteasome inhibitor MG132, suppressed the LPS-induced
degradation of p120ctn, which suggests that autophagy pathway might contribute to the
degradation of p120ctn in macrophage upon E. coli LPS challenge. One of the selective
degradation by autophagy is mediated through autophagy adaptor protein p62 which could
recognize K63-ubiquitinated proteins. Behrends et al reported a proteomic analysis of the
autophagy interaction network in human cells under basal autophagy, which revealed a network
of 751 interactions among 409 candidate interacting proteins [287]. In this research, p120ctn-p62
interaction in HEK293 cells was identified via affinity-capture mass spectrometry by using p62 as
a bait [287]. Selective autophagy can also be mediated by the interaction between LIR motif of the
target and the autophagy protein LC3, which targets selected cargo to a nascent autophagosome.
The core LIR motif is (W/F/Y)XX(L/I/V), where X is any other residue. This sequence is
surrounded by at least one acidic residue [179, 288]. Examination of p120ctn amino-acid sequence
(reference sequence: NP_001078927.1) revealed a potential LIR motif “WAPL” at positions 336339aa upstream of the N-terminal Arm domain. Also, an aspartic acid residue is located upstream
of this motif (-4) together with two tyrosine residues and one serine residue nearby which might
be associated with the mechanism of regulating the protein interactions. Another Arm domain
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family membrane β-catenin was reported to contain a potential LIR motif (WPLI) at positions
504–507 within the Arm domains (Arm 9) [289] . During nutrient deprivation β-catenin was
selectively degraded via the formation of a β-catenin–LC3 complex mediated by the LIR motif.
The interaction between LC3 and β-catenin was required for non-proteasomal degradation of βcatenin [289]. However, the further co-immunoprecipitation and mutation assays are required to
confirm the pathway responsible for p120ctn degradation via selective autophagy in macrophage
upon LPS stimulation. Some other studies reported that p120ctn was phosphorylated by casein
kinase (CK)-1α and glycogen synthase kinase (GSK) 3β, and then degraded through the ubiquitinproteasome pathway. The inhibition of proteasome pathway with MG132 could raise p120ctn
levels in melanoma cells and 293T cells [72]. This indicated the pathways responsible for p120ctn
degradation might be cell-context and signaling-pathway dependent. The activation of GSK3β or
CK-1α signaling led to the proteasomal degradation of p120ctn [72], whereas, LPS-induced Src
activation might be responsible for autophagy degradation of p120ctn.
Comparing the signaling pathways revealed the similar activation patterns of the MAPK,
Akt, and IKK-NF-κB signaling pathways activated by E. coli and P. aeruginosa LPS. p120ctn was
originally identified as a Src substrate from v-Src-transformed chicken embryo fibroblasts [1].
Multiple sites of p120ctn tyrosine phosphorylation by Src were identified [74]. But the functional
consequences of p120ctn tyrosine phosphorylation are not completely understood. Under some
specific circumstances, in vitro and in vivo assays indicated that tyrosine-phosphorylation of
p120ctn was correlated with an altered affinity of p120ctn for cadherins and the structural integrity
of the adherens junctions [75, 81, 290, 291]. The macrophages do not form a static cell-cell
adhesion, therefore, the p120ctn phosphorylation by Src and its degradation induced by LPS might
be associated with the mobility of macrophages in inflammatory responses.
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LPS is the major structural component present in the outer membrane of Gram-negative
bacteria that can trigger innate immune responses through TLR4. LPS is composed of three distinct
units: the hydrophobic phospholipid known as lipid A, a core oligosaccharide, and an outer
polysaccharide called O antigen [292]. Studies employing synthesized lipid A have demonstrated
that lipid A is the major inflammation-inducing moiety of LPS [293, 294]. The diversity of
structural motifs in the polysaccharide and the lipid A moieties accounts for the highly variable in
vivo and in vitro responses to LPS [295]. However, the relationships between diverse structure of
LPS and biological responses are complex, and studies have indicated that LPS isolated from
particular bacterial strains can preferentially induce MyD88- or TRIF-dependent expression of
cytokines [293]. My study revealed that LPS from two different bacterial strains (E. coli and P.
aeruginosa) could induce diverse response in macrophages with respect to p120ctn expression. At
present, the functional significance related to LPS-induced degradation of p120ctn in macrophages
remains elusive. Further studies are required to define whether LPS-induced degradation of
p120ctn is associated with distinct profile of cytokine expression and macrophage mobility.
p120 Catenin suppresses LPS-induced NF-κB activation and proinflammatory
cytokine expression
Previous observations showed that p120-null epidermal cells exhibited increased NF-κB
activation, resulting in elevated expression of proinflammatory cytokines and chemokines in vitro
and in vivo [258, 259]. Wang et al revealed p120ctn expressed in endothelial cells could inhibit
TLR4-mediated NF-κB signaling and lung inflammation [263]. These findings raise the possibility
that p120ctn might have important roles in regulating immunity. In my research, p120ctn
knockdown in macrophages also led to elevated activation of NF-κB signaling and mRNA
expression of proinflammatory cytokines including IL-1β, IL-8, IL-6 and TNF-α. The loss of
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p120ctn could not extend the time period of IKKβ activation, IκBα degradation or NF-κB nuclear
translocation. Instead, p120ctn depletion resulted in more rapid activation of NF-κB signaling
pathway.
A number of kinases have been identified that phosphorylate NF-κB p65 at Ser536 in the
transactivation domain, including IKKα, IKKβ, IKKε and NF-κB activating kinase/TBK1 [296,
297]. The consequences of Ser536 phosphorylation of p65 would depend on the physiological
context. For example, in 293T cells, TNF-α-induced phosphorylation at Ser536 of p65 displays
enhanced transcriptional activity which is associated with increased acetylation of p65 [298].
Moreover, p65 Ser536 phosphorylation leads to the expression of a distinct set of target genes,
which indicates phosphorylation of p65 might be associated with the selectivity of gene expression
[299]. In my research, the phosphorylated p65 at Ser536 was increased transiently in nucleus in
p120ctn knockdown macrophages after LPS stimulation. This might be associated with the
upregulation of proinflammatory expression in p120ctn-depleted macrophages. Further studies are
required to explain the functional association of p65 Ser536 phosphorylation with the cytokine
expression.
p120 Catenin is associate with LPS/TLR4-induced autophagy in THP-1 derived
macrophages
Pattern recognition receptor signaling that is induced following the recognition of PAMPs
and DAMPs can activate autophagy [215, 216]. For example, activation of TLR4 leads to
ubiquitination of the Beclin-1 by the E3 ligase TRAF6. Ubiquitinated Beclin-1 is released from its
inhibitor Bcl-2 and becomes active [154]. TRAF6 also activates ULK1 through ubiquitination
[300]. TLR activation also promotes the interaction of MyD88 and TRIF with Beclin-1, which
reduces the binding of Beclin-1 to Bcl-2 [301].
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Autophagy also facilitates TLR signaling by transferring cytosolic pathogen components
to their cognate endosomal TLRs [227]. Autophagosome plays an important role in delivery of
antigen to antigen-loading compartments for MHC II presentation [302].
Autophagy is a dynamic process through which eukaryotic cells degrade long-lived or
misfolded proteins, and impaired or superfluous cytoplasmic organelles, as well as recycle
autophagy-derived nutrients [303]. Autophagy comprises sequential steps including the formation
of autophagosomes, the fusion of autophagosomes with lysosomes and cargo degradation [121].
Autophagy is associated with a wide range of physiological and pathological processes, such as
embryonic development, immunity, cancer, cardiovascular disease, muscular disease and
neurodegenerative disease [130]. To date, the major methods used to monitor autophagic
activation are the Western blot analysis of LC3 processing and detection of autophagosome
formation by fluorescence or electron microscopy [304]. However, autophagy is a highly dynamic
process with multiple steps. The increased LC3-II levels observed via Western blot or the
accumulation of autophagosomes detected by microscope could indicate either the activation of
autophagy or a blockage of downstream steps in autophagy, such as inefficient fusion or decreased
lysosomal degradation. Therefore, the mere detection of the presence of LC3 processing is
insufficient for an overall evaluation of the entire autophagic system. Evaluation of the rate of
autophagic degradation, defined as autophagic flux, seems more accurate to assess the whole
dynamic process of autophagy [305, 306]. In this research, LPS-induced autophagy was compared
between p120ctn knockdown THP-1 derived macrophages and shRNA control macrophages. The
conversion of LC3-I to LC3-II, an indicator of autophagy activation, was assessed by immunoblot
analysis with LC3 antibody. As shown in Figure 3.9A, LC3-II abundance was increased by LPS
challenge in a time-dependent manner in both p120ctn knockdown macrophages and shRNA
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control macrophages. Generally, without inhibition of autophagy process, LC3-II level was
observed to be gradually increased 8 hours after LPS treatment, and reached the highest level
around 16 hours of LPS treatment. Since the autophagic process is highly dynamic and
autophagosomes turn over rapidly, the absolute level of LC3-II at specific time point after LPS
stimulation might not represent the real rate of autophagy flux unless lysosomal degradation is
blocked. By using bafilomycin A1 to block the fusion of autophagosome with lysosome, an
increase of LC3-II level was observed in both p120ctn knockdown and control macrophages after
LPS challenge (Figure 3.9C). But, the elevated level of LC3-II was significantly lower in p120ctn
knockdown macrophages as compared with control cells. Without LPS stimulation, the inhibition
of autophagy with bafilomycin A1 could also increase the abundance of LC3-II similarly in both
macrophages, suggesting that basal level of autophagy might not be affected by the loss of p120ctn
in macrophages.
p62 has an N-terminal PB1 domain followed by a zinc finger domain, and a C-terminal
UBA domain [307]. p62 could bind to polyubiquitin via its UBA domain and thus recruit
ubiquitinated protein aggregates [308, 309]. The N-terminal PB1 domain is used for the
polymerization of p62 and for binding to other proteins containing PB1 domains [310]. p62,
together with the bound cargoes, is degraded by autophagy, so p62 may also be used as an
autophagic marker [173]. My data demonstrated that LPS could induce a transient downregulation
of p62 followed by upregulation and maintaining at a high level in shRNA control macrophages
(Figure 3.9B). The LPS-induced decrease of p62 was not observed in p120ctn knockdown
macrophages, whereas the gradual increase was evident during the course of LPS challenge.
TRAF6 is the essential mediator for activation of NF-κB pathway induced by LPS,
proinflammatory cytokines and growth factors [311]. p62 also functions to facilitate K63-
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polyubiquitination of TRAF6 and thereby mediates the activation of the NF-κB pathway [311]. As
shown in Figure 3.9 B and D, p62 level was increased by LPS and could not be further elevated
by bafilomycin A1. Hence, the increase of p62 might result from LPS-induced activation of NFκB signaling in THP-1 derived macrophages. This is consistent with another study which
demonstrated that LPS treatment led to induction of p62 mRNA and protein in mouse bone
marrow-derived macrophages [312]. As an adaptor protein, p62 is involved in multiple biologic
processes, such as NF-κB activation and protein degradation via autophagy. The predominant
functions of p62 might be cell-context dependent. p62 may display distinctive functions in
response to different stimuli. In this THP-1 derived macrophage model, instead of autophagic
degradation, p62 might be mainly involved in the activation of NF-κB signaling pathway via
interaction with TRAF6. As the Figure 3.9B showed, the basal level of p62 was lower in p120ctn
knockdown macrophages as compared with control cells. The mechanisms responsible for p62
downregulation in p120ctn-depleted cells remains unclear, and further study is warranted.
Covalently conjugated Atg12-Atg5 forms a multimeric complex with Atg16L1, which
functions as ubiquitin-protein ligase E3-like enzyme essential for LC3-PE conjugation reaction
and therefore for autophagosome formation [313, 314]. Without any stimulation, Atg12 has been
constitutively conjugated to Atg5 [315]. The level of conjugated Atg12-Atg5 was downregulated
8 hours after LPS treatment in p120ctn knockdown macrophages. This might be one of the reasons
for the decreased activity of LPS-induced autophagy in p120ctn knockdown macrophages. The
mechanism by which the loss of p120ctn affects the expression of conjugated Atg12-Atg5 needs
further studies.
4.2 Conclusions
In conclusion, p120ctn has conserved anti-inflammatory functions across different cell
types including epithelial cells, endothelial cells and macrophages. NF-κB signaling pathway
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might be the common regulatory target. The downregulation of p120 catenin in the macrophages
in response to E. coli LPS stimulation might be regulated by Src signaling and autophagy. The
depletion of p120ctn results in the decreased activity of LPS-induced autophagy in THP-1derived
macrophages. The loss of p120ctn leads to downregulation of conjugated Atg12-Atg5 in
macrophages upon LPS stimulation. The abnormal autophagy might contribute to the overactivation of LPS-induced inflammation in p120ctn knockdown macrophages.
4.3 Future directions
The LPS-induced downregulation of p120ctn was revealed in this study. Future research is
required in order to explore how p120ctn is degraded via autophagy and whether the
downregulation of p120ctn is associated with the distinct patterns of proinflammatory cytokine
expression. The defective LPS-induced autophagy was displayed in p120ctn-depleted
macrophages. Further studies will be performed to determine how p120ctn influences Atg12-Atg5
conjugation.

67

REFERENCES
1.

Reynolds, A.B., et al., Transformation-specific tyrosine phosphorylation of a novel cellular
protein in chicken cells expressing oncogenic variants of the avian cellular src gene. Mol
Cell Biol, 1989. 9(2): p. 629-38.

2.

Peifer, M., S. Berg, and A.B. Reynolds, A repeating amino acid motif shared by proteins
with diverse cellular roles. Cell, 1994. 76(5): p. 789-91.

3.

Reynolds, A.B., et al., p120, a novel substrate of protein tyrosine kinase receptors and of
p60v-src, is related to cadherin-binding factors beta-catenin, plakoglobin and armadillo.
Oncogene, 1992. 7(12): p. 2439-45.

4.

Reynolds, A.B., et al., Identification of a new catenin: the tyrosine kinase substrate p120cas
associates with E-cadherin complexes. Mol Cell Biol, 1994. 14(12): p. 8333-42.

5.

Daniel, J.M. and A.B. Reynolds, The tyrosine kinase substrate p120cas binds directly to Ecadherin but not to the adenomatous polyposis coli protein or alpha-catenin. Mol Cell Biol,
1995. 15(9): p. 4819-24.

6.

Reynolds, A.B., et al., The novel catenin p120cas binds classical cadherins and induces an
unusual morphological phenotype in NIH3T3 fibroblasts. Exp Cell Res, 1996. 225(2): p.
328-37.

7.

Chiasson, C.M., et al., p120-catenin inhibits VE-cadherin internalization through a Rhoindependent mechanism. Mol Biol Cell, 2009. 20(7): p. 1970-80.

8.

Nelson, W.J., Regulation of cell-cell adhesion by the cadherin-catenin complex. Biochem
Soc Trans, 2008. 36(Pt 2): p. 149-55.

9.

Kemler, R., From cadherins to catenins: cytoplasmic protein interactions and regulation of
cell adhesion. Trends Genet, 1993. 9(9): p. 317-21.

68

10.

Aberle, H., et al., Assembly of the cadherin-catenin complex in vitro with recombinant
proteins. J Cell Sci, 1994. 107 ( Pt 12): p. 3655-63.

11.

Drees, F., et al., Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin
and regulates actin-filament assembly. Cell, 2005. 123(5): p. 903-15.

12.

Davis, M.A., R.C. Ireton, and A.B. Reynolds, A core function for p120-catenin in cadherin
turnover. J Cell Biol, 2003. 163(3): p. 525-34.

13.

Ireton, R.C., et al., A novel role for p120 catenin in E-cadherin function. J Cell Biol, 2002.
159(3): p. 465-76.

14.

Ishiyama, N., et al., Dynamic and static interactions between p120 catenin and E-cadherin
regulate the stability of cell-cell adhesion. Cell, 2010. 141(1): p. 117-28.

15.

Yap, A.S., C.M. Niessen, and B.M. Gumbiner, The juxtamembrane region of the cadherin
cytoplasmic tail supports lateral clustering, adhesive strengthening, and interaction with
p120ctn. J Cell Biol, 1998. 141(3): p. 779-89.

16.

Chen, H., et al., E-cadherin mediates adhesion and suppresses cell motility via distinct
mechanisms. J Cell Sci, 1997. 110 ( Pt 3): p. 345-56.

17.

Reynolds, A.B. and A. Roczniak-Ferguson, Emerging roles for p120-catenin in cell
adhesion and cancer. Oncogene, 2004. 23(48): p. 7947-56.

18.

Keirsebilck, A., et al., Molecular cloning of the human p120ctn catenin gene (CTNND1):
expression of multiple alternatively spliced isoforms. Genomics, 1998. 50(2): p. 129-46.

19.

van Hengel, J. and F. van Roy, Diverse functions of p120ctn in tumors. Biochim Biophys
Acta, 2007. 1773(1): p. 78-88.

69

20.

Zhang, P.X., et al., p120-catenin isoform 3 regulates subcellular localization of Kaiso and
promotes invasion in lung cancer cells via a phosphorylation-dependent mechanism. Int J
Oncol, 2011. 38(6): p. 1625-35.

21.

Jiang, G., et al., P120-catenin isoforms 1 and 3 regulate proliferation and cell cycle of lung
cancer cells via beta-catenin and Kaiso respectively. PLoS One, 2012. 7(1): p. e30303.

22.

Mo, Y.Y. and A.B. Reynolds, Identification of murine p120 isoforms and heterogeneous
expression of p120cas isoforms in human tumor cell lines. Cancer Res, 1996. 56(11): p.
2633-40.

23.

Liu, X., et al., Interactions between MUC1 and p120 catenin regulate dynamic features of
cell adhesion, motility, and metastasis. Cancer Res, 2014. 74(5): p. 1609-20.

24.

Tewari, R., et al., Armadillo-repeat protein functions: questions for little creatures. Trends
Cell Biol, 2010. 20(8): p. 470-81.

25.

Alema, S. and A.M. Salvatore, p120 catenin and phosphorylation: Mechanisms and traits
of an unresolved issue. Biochim Biophys Acta, 2007. 1773(1): p. 47-58.

26.

Nollet, F., G. Berx, and F. van Roy, The role of the E-cadherin/catenin adhesion complex
in the development and progression of cancer. Mol Cell Biol Res Commun, 1999. 2(2): p.
77-85.

27.

Takeichi, M., Morphogenetic roles of classic cadherins. Curr Opin Cell Biol, 1995. 7(5):
p. 619-27.

28.

Hulsken, J., W. Birchmeier, and J. Behrens, E-cadherin and APC compete for the
interaction with beta-catenin and the cytoskeleton. J Cell Biol, 1994. 127(6 Pt 2): p. 20619.

70

29.

Anastasiadis, P.Z. and A.B. Reynolds, The p120 catenin family: complex roles in adhesion,
signaling and cancer. J Cell Sci, 2000. 113 ( Pt 8): p. 1319-34.

30.

Thoreson, M.A., et al., Selective uncoupling of p120(ctn) from E-cadherin disrupts strong
adhesion. J Cell Biol, 2000. 148(1): p. 189-202.

31.

Xiao, K., et al., Cellular levels of p120 catenin function as a set point for cadherin
expression levels in microvascular endothelial cells. J Cell Biol, 2003. 163(3): p. 535-45.

32.

Xiao, K., et al., Role of p120-catenin in cadherin trafficking. Biochim Biophys Acta, 2007.
1773(1): p. 8-16.

33.

Bryant, D.M. and J.L. Stow, The ins and outs of E-cadherin trafficking. Trends Cell Biol,
2004. 14(8): p. 427-34.

34.

Fujita, Y., et al., Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the
E-cadherin complex. Nat Cell Biol, 2002. 4(3): p. 222-31.

35.

Lee, C.S., J. Sariego, and T. Matsumoto, Changing patterns in the predisposition for
amputation of the lower extremities. Am Surg, 1992. 58(8): p. 474-7.

36.

Balzac, F., et al., E-cadherin endocytosis regulates the activity of Rap1: a traffic light
GTPase at the crossroads between cadherin and integrin function. J Cell Sci, 2005. 118(Pt
20): p. 4765-83.

37.

Ghesquieres, H., Severe interstitial pneumonitis following rituximab and bleomycincontaining combination chemotherapy. Ann Oncol, 2005. 16(8): p. 1399.

38.

Nanes, B.A., et al., p120-catenin binding masks an endocytic signal conserved in classical
cadherins. J Cell Biol, 2012. 199(2): p. 365-80.

71

39.

Miyashita, Y. and M. Ozawa, Increased internalization of p120-uncoupled E-cadherin and
a requirement for a dileucine motif in the cytoplasmic domain for endocytosis of the
protein. J Biol Chem, 2007. 282(15): p. 11540-8.

40.

Sato, K., et al., Numb controls E-cadherin endocytosis through p120 catenin with aPKC.
Mol Biol Cell, 2011. 22(17): p. 3103-19.

41.

Miranda, K.C., et al., Contextual binding of p120ctn to E-cadherin at the basolateral plasma
membrane in polarized epithelia. J Biol Chem, 2003. 278(44): p. 43480-8.

42.

Etienne-Manneville, S. and A. Hall, Rho GTPases in cell biology. Nature, 2002.
420(6916): p. 629-35.

43.

Hall, A., Rho GTPases and the actin cytoskeleton. Science, 1998. 279(5350): p. 509-14.

44.

Jou, T.S. and W.J. Nelson, Effects of regulated expression of mutant RhoA and Rac1 small
GTPases on the development of epithelial (MDCK) cell polarity. J Cell Biol, 1998. 142(1):
p. 85-100.

45.

Hordijk, P.L., et al., Inhibition of invasion of epithelial cells by Tiam1-Rac signaling.
Science, 1997. 278(5342): p. 1464-6.

46.

Takaishi, K., et al., Regulation of cell-cell adhesion by rac and rho small G proteins in
MDCK cells. J Cell Biol, 1997. 139(4): p. 1047-59.

47.

Buhler, F.R., et al., [Plasma catecholamines and hemodynamics in the course of
antihypertensive beta blockade: varying patterns in "propranolol-responders" and "nonresponders"]. Schweiz Med Wochenschr, 1977. 107(44): p. 1590-1.

48.

Wheeler, A.P. and A.J. Ridley, Why three Rho proteins? RhoA, RhoB, RhoC, and cell
motility. Exp Cell Res, 2004. 301(1): p. 43-9.

72

49.

Van Aelst, L. and C. D'Souza-Schorey, Rho GTPases and signaling networks. Genes Dev,
1997. 11(18): p. 2295-322.

50.

Tong, L. and V. Tergaonkar, Rho protein GTPases and their interactions with NFkappaB:
crossroads of inflammation and matrix biology. Biosci Rep, 2014. 34(3).

51.

Marinissen, M.J., M. Chiariello, and J.S. Gutkind, Regulation of gene expression by the
small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes Dev,
2001. 15(5): p. 535-53.

52.

Montaner, S., et al., Activation of serum response factor by RhoA is mediated by the
nuclear factor-kappaB and C/EBP transcription factors. J Biol Chem, 1999. 274(13): p.
8506-15.

53.

Perona, R., et al., Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1
proteins. Genes Dev, 1997. 11(4): p. 463-75.

54.

Sulciner, D.J., et al., rac1 regulates a cytokine-stimulated, redox-dependent pathway
necessary for NF-kappaB activation. Mol Cell Biol, 1996. 16(12): p. 7115-21.

55.

Hill, C.S., J. Wynne, and R. Treisman, The Rho family GTPases RhoA, Rac1, and
CDC42Hs regulate transcriptional activation by SRF. Cell, 1995. 81(7): p. 1159-70.

56.

Grosheva, I., et al., p120 catenin affects cell motility via modulation of activity of Rhofamily GTPases: a link between cell-cell contact formation and regulation of cell
locomotion. J Cell Sci, 2001. 114(Pt 4): p. 695-707.

57.

Anastasiadis, P.Z., et al., Inhibition of RhoA by p120 catenin. Nat Cell Biol, 2000. 2(9): p.
637-44.

58.

Noren, N.K., et al., p120 catenin regulates the actin cytoskeleton via Rho family GTPases.
J Cell Biol, 2000. 150(3): p. 567-80.

73

59.

Yanagisawa, M., et al., A p120 catenin isoform switch affects Rho activity, induces tumor
cell invasion, and predicts metastatic disease. J Biol Chem, 2008. 283(26): p. 18344-54.

60.

Lee, S.H., et al., Synapses are regulated by the cytoplasmic tyrosine kinase Fer in a pathway
mediated by p120catenin, Fer, SHP-2, and beta-catenin. J Cell Biol, 2008. 183(5): p. 893908.

61.

Castano, J., et al., Specific phosphorylation of p120-catenin regulatory domain differently
modulates its binding to RhoA. Mol Cell Biol, 2007. 27(5): p. 1745-57.

62.

Goodwin, M., et al., Minimal mutation of the cytoplasmic tail inhibits the ability of Ecadherin to activate Rac but not phosphatidylinositol 3-kinase: direct evidence of a role for
cadherin-activated Rac signaling in adhesion and contact formation. J Biol Chem, 2003.
278(23): p. 20533-9.

63.

Nimnual, A.S., L.J. Taylor, and D. Bar-Sagi, Redox-dependent downregulation of Rho by
Rac. Nat Cell Biol, 2003. 5(3): p. 236-41.

64.

Sander, E.E., et al., Rac downregulates Rho activity: reciprocal balance between both
GTPases determines cellular morphology and migratory behavior. J Cell Biol, 1999.
147(5): p. 1009-22.

65.

Daniel, J.M., et al., The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding
protein that recognizes both a sequence-specific consensus and methylated CpG
dinucleotides. Nucleic Acids Res, 2002. 30(13): p. 2911-9.

66.

Yoon, H.G., et al., N-CoR mediates DNA methylation-dependent repression through a
methyl CpG binding protein Kaiso. Mol Cell, 2003. 12(3): p. 723-34.

67.

Prokhortchouk, A., et al., The p120 catenin partner Kaiso is a DNA methylation-dependent
transcriptional repressor. Genes Dev, 2001. 15(13): p. 1613-8.

74

68.

Daniel, J.M., Dancing in and out of the nucleus: p120(ctn) and the transcription factor
Kaiso. Biochim Biophys Acta, 2007. 1773(1): p. 59-68.

69.

van Roy, F.M. and P.D. McCrea, A role for Kaiso-p120ctn complexes in cancer? Nat Rev
Cancer, 2005. 5(12): p. 956-64.

70.

Park, J.I., et al., Frodo links Dishevelled to the p120-catenin/Kaiso pathway: distinct
catenin subfamilies promote Wnt signals. Dev Cell, 2006. 11(5): p. 683-95.

71.

Kim, S.W., et al., Non-canonical Wnt signals are modulated by the Kaiso transcriptional
repressor and p120-catenin. Nat Cell Biol, 2004. 6(12): p. 1212-20.

72.

Hong, J.Y., et al., Shared molecular mechanisms regulate multiple catenin proteins:
canonical Wnt signals and components modulate p120-catenin isoform-1 and additional
p120 subfamily members. J Cell Sci, 2010. 123(Pt 24): p. 4351-65.

73.

Li, Y. and D. Kufe, The Human DF3/MUC1 carcinoma-associated antigen signals nuclear
localization of the catenin p120(ctn). Biochem Biophys Res Commun, 2001. 281(2): p.
440-3.

74.

Mariner, D.J., et al., Identification of Src phosphorylation sites in the catenin p120ctn. J
Biol Chem, 2001. 276(30): p. 28006-13.

75.

Calautti, E., et al., Tyrosine phosphorylation and src family kinases control keratinocyte
cell-cell adhesion. J Cell Biol, 1998. 141(6): p. 1449-65.

76.

Downing, J.R. and A.B. Reynolds, PDGF, CSF-1, and EGF induce tyrosine
phosphorylation of p120, a pp60src transformation-associated substrate. Oncogene, 1991.
6(4): p. 607-13.

77.

Kanner, S.B., A.B. Reynolds, and J.T. Parsons, Tyrosine phosphorylation of a 120kilodalton pp60src substrate upon epidermal growth factor and platelet-derived growth

75

factor receptor stimulation and in polyomavirus middle-T-antigen-transformed cells. Mol
Cell Biol, 1991. 11(2): p. 713-20.
78.

Cozzolino, M., et al., p120 Catenin is required for growth factor-dependent cell motility
and scattering in epithelial cells. Mol Biol Cell, 2003. 14(5): p. 1964-77.

79.

Shibamoto, S., et al., Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced
by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell
Adhes Commun, 1994. 1(4): p. 295-305.

80.

Esser, S., et al., Vascular endothelial growth factor induces VE-cadherin tyrosine
phosphorylation in endothelial cells. J Cell Sci, 1998. 111 ( Pt 13): p. 1853-65.

81.

Piedra, J., et al., p120 Catenin-associated Fer and Fyn tyrosine kinases regulate betacatenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction. Mol Cell
Biol, 2003. 23(7): p. 2287-97.

82.

Kim, L. and T.W. Wong, The cytoplasmic tyrosine kinase FER is associated with the
catenin-like substrate pp120 and is activated by growth factors. Mol Cell Biol, 1995. 15(8):
p. 4553-61.

83.

Dennis, J.W., et al., Superiority of end-diastolic volume and ejection fraction
measurements over wedge pressures in evaluating cardiac function during aortic
reconstruction. J Vasc Surg, 1992. 16(3): p. 372-7.

84.

Xu, G., et al., Continuous association of cadherin with beta-catenin requires the nonreceptor tyrosine-kinase Fer. J Cell Sci, 2004. 117(Pt 15): p. 3207-19.

85.

Xia, X., et al., Serine and threonine phospho-specific antibodies to p120-catenin. Hybrid
Hybridomics, 2004. 23(6): p. 343-51.

76

86.

Greer, P., Closing in on the biological functions of Fps/Fes and Fer. Nat Rev Mol Cell Biol,
2002. 3(4): p. 278-89.

87.

Ratcliffe, M.J., L.L. Rubin, and J.M. Staddon, Dephosphorylation of the cadherinassociated p100/p120 proteins in response to activation of protein kinase C in epithelial
cells. J Biol Chem, 1997. 272(50): p. 31894-901.

88.

Xia, X., D.J. Mariner, and A.B. Reynolds, Adhesion-associated and PKC-modulated
changes in serine/threonine phosphorylation of p120-catenin. Biochemistry, 2003. 42(30):
p. 9195-204.

89.

Vandenbroucke St Amant, E., et al., PKCalpha activation of p120-catenin serine 879
phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity. Circ
Res, 2012. 111(6): p. 739-49.

90.

Brown, M.V., et al., PDGF receptor activation induces p120-catenin phosphorylation at
serine 879 via a PKCalpha-dependent pathway. Exp Cell Res, 2009. 315(1): p. 39-49.

91.

Xia, X., et al., p120 serine and threonine phosphorylation is controlled by multiple ligandreceptor pathways but not cadherin ligation. Exp Cell Res, 2006. 312(17): p. 3336-48.

92.

Konstantoulaki, M., P. Kouklis, and A.B. Malik, Protein kinase C modifications of VEcadherin, p120, and beta-catenin contribute to endothelial barrier dysregulation induced by
thrombin. Am J Physiol Lung Cell Mol Physiol, 2003. 285(2): p. L434-42.

93.

Ratcliffe, M.J., C. Smales, and J.M. Staddon, Dephosphorylation of the catenins p120 and
p100 in endothelial cells in response to inflammatory stimuli. Biochem J, 1999. 338 ( Pt
2): p. 471-8.

94.

Wong, E.Y., et al., Vascular endothelial growth factor stimulates dephosphorylation of the
catenins p120 and p100 in endothelial cells. Biochem J, 2000. 346 Pt 1: p. 209-16.

77

95.

Medzhitov, R., P. Preston-Hurlburt, and C.A. Janeway, Jr., A human homologue of the
Drosophila Toll protein signals activation of adaptive immunity. Nature, 1997. 388(6640):
p. 394-7.

96.

O'Neill, L.A., D. Golenbock, and A.G. Bowie, The history of Toll-like receptors redefining innate immunity. Nat Rev Immunol, 2013. 13(6): p. 453-60.

97.

Mogensen, T.H., Pathogen recognition and inflammatory signaling in innate immune
defenses. Clin Microbiol Rev, 2009. 22(2): p. 240-73, Table of Contents.

98.

Werling, D. and T.W. Jungi, TOLL-like receptors linking innate and adaptive immune
response. Vet Immunol Immunopathol, 2003. 91(1): p. 1-12.

99.

Kawai, T. and S. Akira, The role of pattern-recognition receptors in innate immunity:
update on Toll-like receptors. Nat Immunol, 2010. 11(5): p. 373-84.

100.

Qureshi, S.T., et al., Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4).
J Exp Med, 1999. 189(4): p. 615-25.

101.

Flo, T.H., et al., Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by
mannuronic acid polymers. J Biol Chem, 2002. 277(38): p. 35489-95.

102.

Yang, S., et al., Micrococcus luteus teichuronic acids activate human and murine
monocytic cells in a CD14- and toll-like receptor 4-dependent manner. Infect Immun,
2001. 69(4): p. 2025-30.

103.

Kurt-Jones, E.A., et al., Pattern recognition receptors TLR4 and CD14 mediate response
to respiratory syncytial virus. Nat Immunol, 2000. 1(5): p. 398-401.

104.

Vabulas, R.M., et al., Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to
activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol
Chem, 2001. 276(33): p. 31332-9.

78

105.

Ohashi, K., et al., Cutting edge: heat shock protein 60 is a putative endogenous ligand of
the toll-like receptor-4 complex. J Immunol, 2000. 164(2): p. 558-61.

106.

Gondokaryono, S.P., et al., The extra domain A of fibronectin stimulates murine mast cells
via toll-like receptor 4. J Leukoc Biol, 2007. 82(3): p. 657-65.

107.

Okamura, Y., et al., The extra domain A of fibronectin activates Toll-like receptor 4. J Biol
Chem, 2001. 276(13): p. 10229-33.

108.

Huang, S., et al., Saturated fatty acids activate TLR-mediated proinflammatory signaling
pathways. J Lipid Res, 2012. 53(9): p. 2002-13.

109.

Kim, F., et al., Toll-like receptor-4 mediates vascular inflammation and insulin resistance
in diet-induced obesity. Circ Res, 2007. 100(11): p. 1589-96.

110.

Vaure, C. and Y. Liu, A comparative review of toll-like receptor 4 expression and
functionality in different animal species. Front Immunol, 2014. 5: p. 316.

111.

Zarember, K.A. and P.J. Godowski, Tissue expression of human Toll-like receptors and
differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes,
their products, and cytokines. J Immunol, 2002. 168(2): p. 554-61.

112.

Ketloy, C., et al., Expression and function of Toll-like receptors on dendritic cells and other
antigen presenting cells from non-human primates. Vet Immunol Immunopathol, 2008.
125(1-2): p. 18-30.

113.

Hornung, V., et al., Quantitative expression of toll-like receptor 1-10 mRNA in cellular
subsets of human peripheral blood mononuclear cells and sensitivity to CpG
oligodeoxynucleotides. J Immunol, 2002. 168(9): p. 4531-7.

114.

Dasu, M.R., et al., High glucose induces toll-like receptor expression in human monocytes:
mechanism of activation. Diabetes, 2008. 57(11): p. 3090-8.

79

115.

Fitzgerald, K.A., D.C. Rowe, and D.T. Golenbock, Endotoxin recognition and signal
transduction by the TLR4/MD2-complex. Microbes Infect, 2004. 6(15): p. 1361-7.

116.

Akira, S. and K. Takeda, Toll-like receptor signalling. Nat Rev Immunol, 2004. 4(7): p.
499-511.

117.

Lizundia, R., et al., Host species-specific usage of the TLR4-LPS receptor complex. Innate
Immun, 2008. 14(4): p. 223-31.

118.

Yu, B. and S.D. Wright, Catalytic properties of lipopolysaccharide (LPS) binding protein.
Transfer of LPS to soluble CD14. J Biol Chem, 1996. 271(8): p. 4100-5.

119.

Doyle, S.L. and L.A. O'Neill, Toll-like receptors: from the discovery of NFkappaB to new
insights into transcriptional regulations in innate immunity. Biochem Pharmacol, 2006.
72(9): p. 1102-13.

120.

Toshchakov,

V.,

et

al.,

TLR4,

but

not

TLR2,

mediates

IFN-beta-induced

STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol, 2002. 3(4):
p. 392-8.
121.

Glick, D., S. Barth, and K.F. Macleod, Autophagy: cellular and molecular mechanisms. J
Pathol, 2010. 221(1): p. 3-12.

122.

Mizushima, N., Autophagy: process and function. Genes Dev, 2007. 21(22): p. 2861-73.

123.

Yorimitsu, T. and D.J. Klionsky, Autophagy: molecular machinery for self-eating. Cell
Death Differ, 2005. 12 Suppl 2: p. 1542-52.

124.

Kunz, J.B., H. Schwarz, and A. Mayer, Determination of four sequential stages during
microautophagy in vitro. J Biol Chem, 2004. 279(11): p. 9987-96.

125.

Majeski, A.E. and J.F. Dice, Mechanisms of chaperone-mediated autophagy. Int J Biochem
Cell Biol, 2004. 36(12): p. 2435-44.

80

126.

Levine, B. and D.J. Klionsky, Development by self-digestion: molecular mechanisms and
biological functions of autophagy. Dev Cell, 2004. 6(4): p. 463-77.

127.

Kundu, M. and C.B. Thompson, Autophagy: basic principles and relevance to disease.
Annu Rev Pathol, 2008. 3: p. 427-55.

128.

White, E., The role for autophagy in cancer. J Clin Invest, 2015. 125(1): p. 42-6.

129.

Cheng, Y., et al., Therapeutic targeting of autophagy in disease: biology and
pharmacology. Pharmacol Rev, 2013. 65(4): p. 1162-97.

130.

Levine, B. and G. Kroemer, Autophagy in the pathogenesis of disease. Cell, 2008. 132(1):
p. 27-42.

131.

Harris, H. and D.C. Rubinsztein, Control of autophagy as a therapy for neurodegenerative
disease. Nat Rev Neurol, 2011. 8(2): p. 108-17.

132.

Klionsky, D.J., et al., A unified nomenclature for yeast autophagy-related genes. Dev Cell,
2003. 5(4): p. 539-45.

133.

Lamb, C.A., T. Yoshimori, and S.A. Tooze, The autophagosome: origins unknown,
biogenesis complex. Nat Rev Mol Cell Biol, 2013. 14(12): p. 759-74.

134.

Mizushima, N., T. Yoshimori, and Y. Ohsumi, The role of Atg proteins in autophagosome
formation. Annu Rev Cell Dev Biol, 2011. 27: p. 107-32.

135.

Ravikumar, B., et al., Plasma membrane contributes to the formation of preautophagosomal structures. Nat Cell Biol, 2010. 12(8): p. 747-57.

136.

Hailey, D.W., et al., Mitochondria supply membranes for autophagosome biogenesis
during starvation. Cell, 2010. 141(4): p. 656-67.

137.

Yen, W.L., et al., The conserved oligomeric Golgi complex is involved in doublemembrane vesicle formation during autophagy. J Cell Biol, 2010. 188(1): p. 101-14.

81

138.

Hayashi-Nishino, M., et al., A subdomain of the endoplasmic reticulum forms a cradle for
autophagosome formation. Nat Cell Biol, 2009. 11(12): p. 1433-7.

139.

Moreau, K., et al., Autophagosome precursor maturation requires homotypic fusion. Cell,
2011. 146(2): p. 303-17.

140.

Weidberg, H., et al., LC3 and GATE-16 N termini mediate membrane fusion processes
required for autophagosome biogenesis. Dev Cell, 2011. 20(4): p. 444-54.

141.

Geng, J. and D.J. Klionsky, The Atg8 and Atg12 ubiquitin-like conjugation systems in
macroautophagy. 'Protein modifications: beyond the usual suspects' review series. EMBO
Rep, 2008. 9(9): p. 859-64.

142.

Klionsky, D.J. and B.A. Schulman, Dynamic regulation of macroautophagy by distinctive
ubiquitin-like proteins. Nat Struct Mol Biol, 2014. 21(4): p. 336-45.

143.

Wild, P., D.G. McEwan, and I. Dikic, The LC3 interactome at a glance. J Cell Sci, 2014.
127(Pt 1): p. 3-9.

144.

Gordon, P.B. and P.O. Seglen, Prelysosomal convergence of autophagic and endocytic
pathways. Biochem Biophys Res Commun, 1988. 151(1): p. 40-7.

145.

Canton, J., Phagosome maturation in polarized macrophages. J Leukoc Biol, 2014. 96(5):
p. 729-38.

146.

Reggiori, F. and D.J. Klionsky, Autophagic processes in yeast: mechanism, machinery and
regulation. Genetics, 2013. 194(2): p. 341-61.

147.

Yang, Z., et al., Atg22 recycles amino acids to link the degradative and recycling functions
of autophagy. Mol Biol Cell, 2006. 17(12): p. 5094-104.

148.

Sagne, C., et al., Identification and characterization of a lysosomal transporter for small
neutral amino acids. Proc Natl Acad Sci U S A, 2001. 98(13): p. 7206-11.

82

149.

Pattingre, S., et al., Regulation of macroautophagy by mTOR and Beclin 1 complexes.
Biochimie, 2008. 90(2): p. 313-23.

150.

Munson, M.J. and I.G. Ganley, MTOR, PIK3C3, and autophagy: Signaling the beginning
from the end. Autophagy, 2015. 11(12): p. 2375-6.

151.

Jaber, N., et al., Mammalian PIK3C3/VPS34: the key to autophagic processing in liver and
heart. Autophagy, 2012. 8(4): p. 707-8.

152.

Ravikumar, B., et al., Regulation of mammalian autophagy in physiology and
pathophysiology. Physiol Rev, 2010. 90(4): p. 1383-435.

153.

Lindmo, K. and H. Stenmark, Regulation of membrane traffic by phosphoinositide 3kinases. J Cell Sci, 2006. 119(Pt 4): p. 605-14.

154.

Shi, C.S. and J.H. Kehrl, TRAF6 and A20 regulate lysine 63-linked ubiquitination of
Beclin-1 to control TLR4-induced autophagy. Sci Signal, 2010. 3(123): p. ra42.

155.

Wei, Y., et al., JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced
autophagy. Mol Cell, 2008. 30(6): p. 678-88.

156.

Sarbassov, D.D., S.M. Ali, and D.M. Sabatini, Growing roles for the mTOR pathway. Curr
Opin Cell Biol, 2005. 17(6): p. 596-603.

157.

Cherra, S.J., 3rd, et al., Regulation of the autophagy protein LC3 by phosphorylation. J
Cell Biol, 2010. 190(4): p. 533-9.

158.

Mizushima, N. and M. Komatsu, Autophagy: renovation of cells and tissues. Cell, 2011.
147(4): p. 728-41.

159.

Kuma, A., et al., The role of autophagy during the early neonatal starvation period. Nature,
2004. 432(7020): p. 1032-6.

83

160.

Kopitz, J., et al., Nonselective autophagy of cytosolic enzymes by isolated rat hepatocytes.
J Cell Biol, 1990. 111(3): p. 941-53.

161.

Khaminets, A., C. Behl, and I. Dikic, Ubiquitin-Dependent And Independent Signals In
Selective Autophagy. Trends Cell Biol, 2016. 26(1): p. 6-16.

162.

Rogov, V., et al., Interactions between autophagy receptors and ubiquitin-like proteins
form the molecular basis for selective autophagy. Mol Cell, 2014. 53(2): p. 167-78.

163.

Hubbard, V.M., et al., Selective autophagy in the maintenance of cellular homeostasis in
aging organisms. Biogerontology, 2012. 13(1): p. 21-35.

164.

Kraft, C., F. Reggiori, and M. Peter, Selective types of autophagy in yeast. Biochim
Biophys Acta, 2009. 1793(9): p. 1404-12.

165.

McEwan, D.G. and I. Dikic, The Three Musketeers of Autophagy: phosphorylation,
ubiquitylation and acetylation. Trends Cell Biol, 2011. 21(4): p. 195-201.

166.

Johansen, T. and T. Lamark, Selective autophagy mediated by autophagic adapter proteins.
Autophagy, 2011. 7(3): p. 279-96.

167.

Noda, N.N., Y. Ohsumi, and F. Inagaki, Atg8-family interacting motif crucial for selective
autophagy. FEBS Lett, 2010. 584(7): p. 1379-85.

168.

Mancias, J.D., et al., Quantitative proteomics identifies NCOA4 as the cargo receptor
mediating ferritinophagy. Nature, 2014. 509(7498): p. 105-9.

169.

Arosio, P., R. Ingrassia, and P. Cavadini, Ferritins: a family of molecules for iron storage,
antioxidation and more. Biochim Biophys Acta, 2009. 1790(7): p. 589-99.

170.

Dowdle, W.E., et al., Selective VPS34 inhibitor blocks autophagy and uncovers a role for
NCOA4 in ferritin degradation and iron homeostasis in vivo. Nat Cell Biol, 2014. 16(11):
p. 1069-79.

84

171.

Kurz, T., et al., Lysosomes in iron metabolism, ageing and apoptosis. Histochem Cell Biol,
2008. 129(4): p. 389-406.

172.

Zheng, Y.T., et al., The adaptor protein p62/SQSTM1 targets invading bacteria to the
autophagy pathway. J Immunol, 2009. 183(9): p. 5909-16.

173.

Pankiv, S., et al., p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of
ubiquitinated protein aggregates by autophagy. J Biol Chem, 2007. 282(33): p. 24131-45.

174.

Matsumoto, G., et al., Serine 403 phosphorylation of p62/SQSTM1 regulates selective
autophagic clearance of ubiquitinated proteins. Mol Cell, 2011. 44(2): p. 279-89.

175.

Wurzer, B., et al., Oligomerization of p62 allows for selection of ubiquitinated cargo and
isolation membrane during selective autophagy. Elife, 2015. 4: p. e08941.

176.

Komander, D. and M. Rape, The ubiquitin code. Annu Rev Biochem, 2012. 81: p. 203-29.

177.

Tan, J.M., et al., Lysine 63-linked ubiquitination promotes the formation and autophagic
clearance of protein inclusions associated with neurodegenerative diseases. Hum Mol
Genet, 2008. 17(3): p. 431-9.

178.

Long, J., et al., Ubiquitin recognition by the ubiquitin-associated domain of p62 involves
a novel conformational switch. J Biol Chem, 2008. 283(9): p. 5427-40.

179.

Birgisdottir, A.B., T. Lamark, and T. Johansen, The LIR motif - crucial for selective
autophagy. J Cell Sci, 2013. 126(Pt 15): p. 3237-47.

180.

Mizushima, N., et al., Autophagy fights disease through cellular self-digestion. Nature,
2008. 451(7182): p. 1069-75.

181.

Tsukamoto, S., et al., Autophagy is essential for preimplantation development of mouse
embryos. Science, 2008. 321(5885): p. 117-20.

85

182.

Kundu, M., et al., Ulk1 plays a critical role in the autophagic clearance of mitochondria
and ribosomes during reticulocyte maturation. Blood, 2008. 112(4): p. 1493-502.

183.

Pua, H.H., et al., Autophagy is essential for mitochondrial clearance in mature T
lymphocytes. J Immunol, 2009. 182(7): p. 4046-55.

184.

Nedjic, J., et al., Autophagy in thymic epithelium shapes the T-cell repertoire and is
essential for tolerance. Nature, 2008. 455(7211): p. 396-400.

185.

Baerga, R., et al., Targeted deletion of autophagy-related 5 (atg5) impairs adipogenesis in
a cellular model and in mice. Autophagy, 2009. 5(8): p. 1118-30.

186.

Lunemann, J.D., et al., Beta-amyloid is a substrate of autophagy in sporadic inclusion body
myositis. Ann Neurol, 2007. 61(5): p. 476-83.

187.

Perlmutter, D.H., The role of autophagy in alpha-1-antitrypsin deficiency: a specific
cellular response in genetic diseases associated with aggregation-prone proteins.
Autophagy, 2006. 2(4): p. 258-63.

188.

Terman, A. and U.T. Brunk, Autophagy in cardiac myocyte homeostasis, aging, and
pathology. Cardiovasc Res, 2005. 68(3): p. 355-65.

189.

Miracco, C., et al., Protein and mRNA expression of autophagy gene Beclin 1 in human
brain tumours. Int J Oncol, 2007. 30(2): p. 429-36.

190.

Liang, X.H., et al., Induction of autophagy and inhibition of tumorigenesis by beclin 1.
Nature, 1999. 402(6762): p. 672-6.

191.

Karantza-Wadsworth, V., et al., Autophagy mitigates metabolic stress and genome damage
in mammary tumorigenesis. Genes Dev, 2007. 21(13): p. 1621-35.

192.

Mathew, R., et al., Autophagy suppresses tumor progression by limiting chromosomal
instability. Genes Dev, 2007. 21(11): p. 1367-81.

86

193.

Qin, L., et al., ER stress negatively regulates AKT/TSC/mTOR pathway to enhance
autophagy. Autophagy, 2010. 6(2): p. 239-47.

194.

Feng, Z., et al., The coordinate regulation of the p53 and mTOR pathways in cells. Proc
Natl Acad Sci U S A, 2005. 102(23): p. 8204-9.

195.

Levine, B. and V. Deretic, Unveiling the roles of autophagy in innate and adaptive
immunity. Nat Rev Immunol, 2007. 7(10): p. 767-77.

196.

Levine, B., N. Mizushima, and H.W. Virgin, Autophagy in immunity and inflammation.
Nature, 2011. 469(7330): p. 323-35.

197.

Gutierrez, M.G., et al., Autophagy is a defense mechanism inhibiting BCG and
Mycobacterium tuberculosis survival in infected macrophages. Cell, 2004. 119(6): p. 75366.

198.

Nakagawa, I., et al., Autophagy defends cells against invading group A Streptococcus.
Science, 2004. 306(5698): p. 1037-40.

199.

Saitoh, T., et al., Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL1beta production. Nature, 2008. 456(7219): p. 264-8.

200.

Dengjel, J., et al., Autophagy promotes MHC class II presentation of peptides from
intracellular source proteins. Proc Natl Acad Sci U S A, 2005. 102(22): p. 7922-7.

201.

Paludan, C., et al., Endogenous MHC class II processing of a viral nuclear antigen after
autophagy. Science, 2005. 307(5709): p. 593-6.

202.

Pua, H.H., et al., A critical role for the autophagy gene Atg5 in T cell survival and
proliferation. J Exp Med, 2007. 204(1): p. 25-31.

203.

Deretic, V., T. Saitoh, and S. Akira, Autophagy in infection, inflammation and immunity.
Nat Rev Immunol, 2013. 13(10): p. 722-37.

87

204.

Clarke, A.J., et al., Autophagy is activated in systemic lupus erythematosus and required
for plasmablast development. Ann Rheum Dis, 2015. 74(5): p. 912-20.

205.

Cadwell, K., et al., A key role for autophagy and the autophagy gene Atg16l1 in mouse
and human intestinal Paneth cells. Nature, 2008. 456(7219): p. 259-63.

206.

Orvedahl, A. and B. Levine, Eating the enemy within: autophagy in infectious diseases.
Cell Death Differ, 2009. 16(1): p. 57-69.

207.

Shibutani, S.T., et al., Autophagy and autophagy-related proteins in the immune system.
Nat Immunol, 2015. 16(10): p. 1014-24.

208.

Henault, J., et al., Noncanonical autophagy is required for type I interferon secretion in
response to DNA-immune complexes. Immunity, 2012. 37(6): p. 986-97.

209.

Sanjuan, M.A., et al., Toll-like receptor signalling in macrophages links the autophagy
pathway to phagocytosis. Nature, 2007. 450(7173): p. 1253-7.

210.

Thurston, T.L., et al., Galectin 8 targets damaged vesicles for autophagy to defend cells
against bacterial invasion. Nature, 2012. 482(7385): p. 414-8.

211.

Wild, P., et al., Phosphorylation of the autophagy receptor optineurin restricts Salmonella
growth. Science, 2011. 333(6039): p. 228-33.

212.

Thurston, T.L., et al., The TBK1 adaptor and autophagy receptor NDP52 restricts the
proliferation of ubiquitin-coated bacteria. Nat Immunol, 2009. 10(11): p. 1215-21.

213.

Ogawa, M., et al., A Tecpr1-dependent selective autophagy pathway targets bacterial
pathogens. Cell Host Microbe, 2011. 9(5): p. 376-89.

214.

Travassos, L.H., et al., Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the
plasma membrane at the site of bacterial entry. Nat Immunol, 2010. 11(1): p. 55-62.

88

215.

Delgado, M.A., et al., Toll-like receptors control autophagy. EMBO J, 2008. 27(7): p.
1110-21.

216.

Xu, Y., et al., Toll-like receptor 4 is a sensor for autophagy associated with innate
immunity. Immunity, 2007. 27(1): p. 135-44.

217.

Rouschop, K.M., et al., The unfolded protein response protects human tumor cells during
hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest,
2010. 120(1): p. 127-41.

218.

Zhou, Y.Y., et al., MAPK/JNK signaling: A potential autophagy regulation pathway.
Biosci Rep, 2015.

219.

Criollo, A., et al., The IKK complex contributes to the induction of autophagy. EMBO J,
2010. 29(3): p. 619-31.

220.

Saitoh, T. and S. Akira, Regulation of innate immune responses by autophagy-related
proteins. J Cell Biol, 2010. 189(6): p. 925-35.

221.

Cooney, R., et al., NOD2 stimulation induces autophagy in dendritic cells influencing
bacterial handling and antigen presentation. Nat Med, 2010. 16(1): p. 90-7.

222.

Watson, R.O., P.S. Manzanillo, and J.S. Cox, Extracellular M. tuberculosis DNA targets
bacteria for autophagy by activating the host DNA-sensing pathway. Cell, 2012. 150(4): p.
803-15.

223.

Birmingham, C.L., et al., Autophagy controls Salmonella infection in response to damage
to the Salmonella-containing vacuole. J Biol Chem, 2006. 281(16): p. 11374-83.

224.

Yordy, B., et al., A neuron-specific role for autophagy in antiviral defense against herpes
simplex virus. Cell Host Microbe, 2012. 12(3): p. 334-45.

89

225.

Kyei, G.B., et al., Autophagy pathway intersects with HIV-1 biosynthesis and regulates
viral yields in macrophages. J Cell Biol, 2009. 186(2): p. 255-68.

226.

Orvedahl, A., et al., HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1
autophagy protein. Cell Host Microbe, 2007. 1(1): p. 23-35.

227.

Lee, H.K., et al., Autophagy-dependent viral recognition by plasmacytoid dendritic cells.
Science, 2007. 315(5817): p. 1398-401.

228.

Talloczy, Z., H.W.t. Virgin, and B. Levine, PKR-dependent autophagic degradation of
herpes simplex virus type 1. Autophagy, 2006. 2(1): p. 24-9.

229.

Harris, J., Autophagy and cytokines. Cytokine, 2011. 56(2): p. 140-4.

230.

Mostowy, S., et al., p62 and NDP52 proteins target intracytosolic Shigella and Listeria to
different autophagy pathways. J Biol Chem, 2011. 286(30): p. 26987-95.

231.

Pilli, M., et al., TBK-1 promotes autophagy-mediated antimicrobial defense by controlling
autophagosome maturation. Immunity, 2012. 37(2): p. 223-34.

232.

Cao, Z., et al., TRAF6 is a signal transducer for interleukin-1. Nature, 1996. 383(6599): p.
443-6.

233.

Tal, M.C., et al., Absence of autophagy results in reactive oxygen species-dependent
amplification of RLR signaling. Proc Natl Acad Sci U S A, 2009. 106(8): p. 2770-5.

234.

Saitoh, T., et al., Atg9a controls dsDNA-driven dynamic translocation of STING and the
innate immune response. Proc Natl Acad Sci U S A, 2009. 106(49): p. 20842-6.

235.

Schroder, K. and J. Tschopp, The inflammasomes. Cell, 2010. 140(6): p. 821-32.

236.

Davis, B.K., H. Wen, and J.P. Ting, The inflammasome NLRs in immunity, inflammation,
and associated diseases. Annu Rev Immunol, 2011. 29: p. 707-35.

90

237.

Yuk, J.M. and E.K. Jo, Crosstalk between autophagy and inflammasomes. Mol Cells, 2013.
36(5): p. 393-9.

238.

Rodgers, M.A., et al., Regulation where autophagy intersects the inflammasome. Antioxid
Redox Signal, 2014. 20(3): p. 495-506.

239.

Nakahira, K., et al., Autophagy proteins regulate innate immune responses by inhibiting
the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol,
2011. 12(3): p. 222-30.

240.

Shi, C.S., et al., Activation of autophagy by inflammatory signals limits IL-1beta
production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol, 2012.
13(3): p. 255-63.

241.

Qu, X., et al., Autophagy gene-dependent clearance of apoptotic cells during embryonic
development. Cell, 2007. 128(5): p. 931-46.

242.

Teplova, I., et al., ATG proteins mediate efferocytosis and suppress inflammation in
mammary involution. Autophagy, 2013. 9(4): p. 459-75.

243.

Lee, H.K., et al., In vivo requirement for Atg5 in antigen presentation by dendritic cells.
Immunity, 2010. 32(2): p. 227-39.

244.

Mortensen, M., et al., The autophagy protein Atg7 is essential for hematopoietic stem cell
maintenance. J Exp Med, 2011. 208(3): p. 455-67.

245.

Paul, S., et al., Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor
activation of NF-kappaB. Immunity, 2012. 36(6): p. 947-58.

246.

Pengo, N., et al., Plasma cells require autophagy for sustainable immunoglobulin
production. Nat Immunol, 2013. 14(3): p. 298-305.

91

247.

Barrett, J.C., et al., Genome-wide association defines more than 30 distinct susceptibility
loci for Crohn's disease. Nat Genet, 2008. 40(8): p. 955-62.

248.

Gateva, V., et al., A large-scale replication study identifies TNIP1, PRDM1, JAZF1,
UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet, 2009.
41(11): p. 1228-33.

249.

Yang, L., et al., Defective hepatic autophagy in obesity promotes ER stress and causes
insulin resistance. Cell Metab, 2010. 11(6): p. 467-78.

250.

Rodriguez, A., et al., Mature-onset obesity and insulin resistance in mice deficient in the
signaling adapter p62. Cell Metab, 2006. 3(3): p. 211-22.

251.

Cadwell, K., et al., Virus-plus-susceptibility gene interaction determines Crohn's disease
gene Atg16L1 phenotypes in intestine. Cell, 2010. 141(7): p. 1135-45.

252.

Han, J.W., et al., Genome-wide association study in a Chinese Han population identifies
nine new susceptibility loci for systemic lupus erythematosus. Nat Genet, 2009. 41(11): p.
1234-7.

253.

International Consortium for Systemic Lupus Erythematosus, G., et al., Genome-wide
association scan in women with systemic lupus erythematosus identifies susceptibility
variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet, 2008. 40(2): p. 204-10.

254.

Jounai, N., et al., The Atg5 Atg12 conjugate associates with innate antiviral immune
responses. Proc Natl Acad Sci U S A, 2007. 104(35): p. 14050-5.

255.

Hotamisligil, G.S., Inflammation and metabolic disorders. Nature, 2006. 444(7121): p.
860-7.

256.

Smalley-Freed, W.G., et al., Adenoma formation following limited ablation of p120catenin in the mouse intestine. PLoS One, 2011. 6(5): p. e19880.

92

257.

Smalley-Freed, W.G., et al., p120-catenin is essential for maintenance of barrier function
and intestinal homeostasis in mice. J Clin Invest, 2010. 120(6): p. 1824-35.

258.

Perez-Moreno, M., et al., Loss of p120 catenin and links to mitotic alterations,
inflammation, and skin cancer. Proc Natl Acad Sci U S A, 2008. 105(40): p. 15399-404.

259.

Perez-Moreno, M., et al., p120-catenin mediates inflammatory responses in the skin. Cell,
2006. 124(3): p. 631-44.

260.

O'Donnell, J.J., 3rd, et al., Loss of p120 catenin upregulates transcription of proinflammatory adhesion molecules in human endothelial cells. Microvasc Res, 2011. 82(2):
p. 105-12.

261.

Alcaide, P., et al., p120-Catenin regulates leukocyte transmigration through an effect on
VE-cadherin phosphorylation. Blood, 2008. 112(7): p. 2770-9.

262.

Karayiannakis, A.J., et al., Expression of catenins and E-cadherin during epithelial
restitution in inflammatory bowel disease. J Pathol, 1998. 185(4): p. 413-8.

263.

Wang, Y.L., et al., Innate immune function of the adherens junction protein p120-catenin
in endothelial response to endotoxin. J Immunol, 2011. 186(5): p. 3180-7.

264.

Gong, P., et al., TLR4 signaling is coupled to SRC family kinase activation, tyrosine
phosphorylation of zonula adherens proteins, and opening of the paracellular pathway in
human lung microvascular endothelia. J Biol Chem, 2008. 283(19): p. 13437-49.

265.

Yang, Z., et al., Differential role for p120-catenin in regulation of TLR4 signaling in
macrophages. J Immunol, 2014. 193(4): p. 1931-41.

266.

Anwar, K.N., et al., RhoA/Rho-associated kinase pathway selectively regulates thrombininduced intercellular adhesion molecule-1 expression in endothelial cells via activation of

93

I kappa B kinase beta and phosphorylation of RelA/p65. J Immunol, 2004. 173(11): p.
6965-72.
267.

Segain, J.P., et al., Rho kinase blockade prevents inflammation via nuclear factor kappa B
inhibition: evidence in Crohn's disease and experimental colitis. Gastroenterology, 2003.
124(5): p. 1180-7.

268.

Paredes, J., et al., Expression of p120-catenin isoforms correlates with genomic and
transcriptional phenotype of breast cancer cell lines. Cell Oncol, 2007. 29(6): p. 467-76.

269.

Roskoski, R., Jr., Src kinase regulation by phosphorylation and dephosphorylation.
Biochem Biophys Res Commun, 2005. 331(1): p. 1-14.

270.

Yamamoto, A., et al., Bafilomycin A1 prevents maturation of autophagic vacuoles by
inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4II-E cells. Cell Struct Funct, 1998. 23(1): p. 33-42.

271.

Angus, D.C., et al., Epidemiology of severe sepsis in the United States: analysis of
incidence, outcome, and associated costs of care. Crit Care Med, 2001. 29(7): p. 1303-10.

272.

Vincent, J.L., et al., International study of the prevalence and outcomes of infection in
intensive care units. JAMA, 2009. 302(21): p. 2323-9.

273.

Bone, R.C., Gram-negative sepsis: a dilemma of modern medicine. Clin Microbiol Rev,
1993. 6(1): p. 57-68.

274.

Opal, S.M., The host response to endotoxin, antilipopolysaccharide strategies, and the
management of severe sepsis. Int J Med Microbiol, 2007. 297(5): p. 365-77.

275.

Brandtzaeg, P., et al., Plasma endotoxin as a predictor of multiple organ failure and death
in systemic meningococcal disease. J Infect Dis, 1989. 159(2): p. 195-204.

94

276.

Moreillon, P. and P.A. Majcherczyk, Proinflammatory activity of cell-wall constituents
from gram-positive bacteria. Scand J Infect Dis, 2003. 35(9): p. 632-41.

277.

Takeuchi, O., et al., Differential roles of TLR2 and TLR4 in recognition of gram-negative
and gram-positive bacterial cell wall components. Immunity, 1999. 11(4): p. 443-51.

278.

Tsuchiya, S., et al., Establishment and characterization of a human acute monocytic
leukemia cell line (THP-1). Int J Cancer, 1980. 26(2): p. 171-6.

279.

Daigneault, M., et al., The identification of markers of macrophage differentiation in PMAstimulated THP-1 cells and monocyte-derived macrophages. PLoS One, 2010. 5(1): p.
e8668.

280.

Schwende, H., et al., Differences in the state of differentiation of THP-1 cells induced by
phorbol ester and 1,25-dihydroxyvitamin D3. J Leukoc Biol, 1996. 59(4): p. 555-61.

281.

Qin, Z., The use of THP-1 cells as a model for mimicking the function and regulation of
monocytes and macrophages in the vasculature. Atherosclerosis, 2012. 221(1): p. 2-11.

282.

Mangan, D.F. and S.M. Wahl, Differential regulation of human monocyte programmed
cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol,
1991. 147(10): p. 3408-12.

283.

Montonen, O., et al., Tissue distribution and cell type-specific expression of p120ctn
isoforms. J Histochem Cytochem, 2001. 49(12): p. 1487-96.

284.

Aho, S., K. Rothenberger, and J. Uitto, Human p120ctn catenin: tissue-specific expression
of isoforms and molecular interactions with BP180/type XVII collagen. J Cell Biochem,
1999. 73(3): p. 390-9.

95

285.

Zhang, Y., et al., Impact of p120-catenin isoforms 1A and 3A on epithelial mesenchymal
transition of lung cancer cells expressing E-cadherin in different subcellular locations.
PLoS One, 2014. 9(2): p. e88064.

286.

Wang, M., et al., Involvement of p120 in LPS-induced NF-kappaB activation and IL-8
production in human bronchial epithelial cells. Toxicol Lett, 2010. 195(1): p. 75-81.

287.

Behrends, C., et al., Network organization of the human autophagy system. Nature, 2010.
466(7302): p. 68-76.

288.

Noda, N.N., et al., Structural basis of target recognition by Atg8/LC3 during selective
autophagy. Genes Cells, 2008. 13(12): p. 1211-8.

289.

Petherick, K.J., et al., Autolysosomal beta-catenin degradation regulates Wnt-autophagyp62 crosstalk. EMBO J, 2013. 32(13): p. 1903-16.

290.

Roura, S., et al., Regulation of E-cadherin/Catenin association by tyrosine phosphorylation.
J Biol Chem, 1999. 274(51): p. 36734-40.

291.

Kinch, M.S., et al., Tyrosine phosphorylation regulates the adhesions of ras-transformed
breast epithelia. J Cell Biol, 1995. 130(2): p. 461-71.

292.

Caroff, M., et al., Structural and functional analyses of bacterial lipopolysaccharides.
Microbes Infect, 2002. 4(9): p. 915-26.

293.

Gaekwad, J., et al., Differential induction of innate immune responses by synthetic lipid a
derivatives. J Biol Chem, 2010. 285(38): p. 29375-86.

294.

Galanos, C., et al., Synthetic and natural Escherichia coli free lipid A express identical
endotoxic activities. Eur J Biochem, 1985. 148(1): p. 1-5.

295.

Darveau, R.P., Lipid A diversity and the innate host response to bacterial infection. Curr
Opin Microbiol, 1998. 1(1): p. 36-42.

96

296.

Buss, H., et al., Constitutive and interleukin-1-inducible phosphorylation of p65 NF{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase
(IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding
protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem, 2004.
279(53): p. 55633-43.

297.

Sakurai, H., et al., IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536
in the transactivation domain. J Biol Chem, 1999. 274(43): p. 30353-6.

298.

Chen, L.F., et al., NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol Cell
Biol, 2005. 25(18): p. 7966-75.

299.

Sasaki, C.Y., et al., Phosphorylation of RelA/p65 on serine 536 defines an
I{kappa}B{alpha}-independent NF-{kappa}B pathway. J Biol Chem, 2005. 280(41): p.
34538-47.

300.

Nazio, F., et al., mTOR inhibits autophagy by controlling ULK1 ubiquitylation, selfassociation and function through AMBRA1 and TRAF6. Nat Cell Biol, 2013. 15(4): p.
406-16.

301.

Shi, C.S. and J.H. Kehrl, MyD88 and Trif target Beclin 1 to trigger autophagy in
macrophages. J Biol Chem, 2008. 283(48): p. 33175-82.

302.

Schmid, D. and C. Munz, Innate and adaptive immunity through autophagy. Immunity,
2007. 27(1): p. 11-21.

303.

Klionsky, D.J. and S.D. Emr, Autophagy as a regulated pathway of cellular degradation.
Science, 2000. 290(5497): p. 1717-21.

97

304.

Mizushima, N., T. Yoshimori, and B. Levine, Methods in mammalian autophagy research.
Cell, 2010. 140(3): p. 313-26.

305.

Loos, B., A. du Toit, and J.H. Hofmeyr, Defining and measuring autophagosome fluxconcept and reality. Autophagy, 2014. 10(11): p. 2087-96.

306.

Mizushima, N. and T. Yoshimori, How to interpret LC3 immunoblotting. Autophagy,
2007. 3(6): p. 542-5.

307.

Moscat, J., M.T. Diaz-Meco, and M.W. Wooten, Signal integration and diversification
through the p62 scaffold protein. Trends Biochem Sci, 2007. 32(2): p. 95-100.

308.

Donaldson, K.M., et al., Ubiquitin-mediated sequestration of normal cellular proteins into
polyglutamine aggregates. Proc Natl Acad Sci U S A, 2003. 100(15): p. 8892-7.

309.

Vadlamudi, R.K., et al., p62, a phosphotyrosine-independent ligand of the SH2 domain of
p56lck, belongs to a new class of ubiquitin-binding proteins. J Biol Chem, 1996. 271(34):
p. 20235-7.

310.

Nakamura, K., et al., PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates
NF-kappaB activation. J Biol Chem, 2010. 285(3): p. 2077-89.

311.

Wooten, M.W., et al., The p62 scaffold regulates nerve growth factor-induced NF-kappaB
activation by influencing TRAF6 polyubiquitination. J Biol Chem, 2005. 280(42): p.
35625-9.

312.

Zhong, Z., et al., NF-kappaB Restricts Inflammasome Activation via Elimination of
Damaged Mitochondria. Cell, 2016. 164(5): p. 896-910.

313.

Mizushima, N., T. Noda, and Y. Ohsumi, Apg16p is required for the function of the
Apg12p-Apg5p conjugate in the yeast autophagy pathway. EMBO J, 1999. 18(14): p.
3888-96.

98

314.

Farkas, L.G., [Utilization of Filatov's cylindric flap in plastic surgery of lower extremities
and trunk]. Cas Lek Cesk, 1951. 90(30): p. 916-20.

315.

Mizushima, N., et al., A protein conjugation system essential for autophagy. Nature, 1998.
395(6700): p. 395-8.

99

ABSTRACT
P120 CATENIN REGULATES INFLAMMATION IN MACROPHAGE

by
XIAOQING GUAN
May 2017
Advisor: Dr. Chunying Li
Major: Biochemistry
Degree: Doctor of Philosophy
Objective: p120 catenin (p120ctn) has been reported to play a critical role in maintenance
of the stability of adherens junctions. It also has potential anti-inflammatory effects in epithelial
and endothelial cells. This research was designed to evaluate the effects of p120ctn on
inflammatory responses in human macrophages upon LPS stimulation, as well as the possible
mechanism by which p120ctn regulates LPS-induced proinflammatory response in macrophages.
Methods: THP-1 cells were induced to differentiate into macrophages by PMA. The isoforms of
p120ctn were identified via RT-PCR and Western blot. The expression of p120ctn was examined
by Western blot in THP-1 derived macrophages after LPS challenge. p120ctn was knocked down
in THP-1 cells by using shRNA lentivirus particles. mRNA level of proinflammatory cytokines
were evaluated by RT-PCR. The autophagy pathway was analyzed by Western blot in
macrophages after LPS stimulation with or without Bafilomycin A1 treatment. Results: THP-1
derived macrophages expressed p120ctn isoform 1A and 3A. E. coli LPS could downregulate
p120ctn expression in macrophage via autophagy pathway, which was suppressed by Src signaling
inhibitor PP2. mRNA levels of proinflammatory cytokines including IL-1β, IL-8, IL-6 and TNFα were elevated in p120ctn-delpeted macrophages in response to LPS stimulation, as compared
with control cells. The activation of NF-κB signaling pathway was more rapid in p120ctn
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knockdown macrophages in response to LPS treatment. Decreased autophagy and downregulation
of conjugated Atg12-Atg5 were observed in p120ctn knockdown macrophages after LPS
challenge. Conclusions: The downregulation of p120ctn in the macrophages in response to E. coli
LPS stimulation is regulated by Src signaling and autophagy. p120ctn has anti-inflammatory
functions in macrophages. NF-κB signaling pathway might be the regulatory target. The loss of
p120ctn results in the decreased activity of LPS-induced autophagy and downregulation of
conjugated Atg12-Atg5 in macrophages upon LPS stimulation, which might contribute to the overactivation of LPS-induced inflammation in p120ctn knockdown macrophages.
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